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1. Introduction
Computed Tomography (CT) was first introduced as a medical device in the 1970’s, and has
since become a ubiquitous imaging tool. Recent technical advances including faster scan times,
improved spatial resolution, and advanced multi-planar reconstruction techniques have led to
the application of CT for the evaluation of numerous anatomic abnormalities and disease
processes. Approximately 3 million CT scans were performed annually in the United States in
1980, but by 2008 that number had grown to 67 million and it continues to rise. [1] Over two-
thirds of all medical radiation is attributable to CT, with 75% of CT scans being performed in the
hospital setting. Approximately 40% of CT scans are of the head/neck/spine, 10% of the chest,
47% of the abdomen/pelvis, and the remainder of the extremities or as a procedural tool. [2, 3, 4]
Increasing awareness of medical radiation has paralleled the increase in CT usage with
permeation into the popular and scientific press. This has resulted in an emphasis by several
organizations on reducing overall medical radiation exposure without compromising diag‐
nostic accuracy and usefulness. Despite this increased awareness and attention, the signifi‐
cance of the increased radiation exposure to the population caused by CT remains unclear.
High levels of ionizing radiation exposure are known to increase cancer risk [5, 6, 7] but the
data for lower doses of radiation, like those seen during medical imaging (including CT), is
less clear and remains controversial. [8, 9, 10] Therefore, in the absence of clarity on this topic,
the American College of Radiology (ACR), Health Physics Society (HPS) and other interested
organizations have adopted the principles of As Low As Reasonably Achievable (ALARA), Image
Gently in pediatrics and Image Wisely in adults. The common theme of all of these guidelines
is to advise physicians to limit radiation exposure to only what is medically necessary. [11, 12]
© 2013 Guite et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
Several strategies to reduce CT-associated radiation have been attempted. One strategy is to
vet CT as the appropriate diagnostic test with preferential use of other imaging modalities
such as ultrasound and MRI when able, particularly in pediatrics, and to limit the CT exami‐
nation to the anatomic area in question. A second strategy involves optimizing scanning
parameters (such as kVp, pitch and mA) in order to reduce exposure in all patient populations.
[13, 14, 15] If CT is felt to be necessary, applying optimized technical parameters and limiting
the scan area can substantially reduce radiation exposure and result in dose reductions as high
as 65%. [12, 15] These important techniques are described in other chapters of this book and
are not our focus. Rather, we will concentrate on an important, but potentially overlooked
source of unnecessary medical radiation, namely, multiphase examinations. We will discuss
how multiphasic examination should be used in abdominal imaging with an emphasis on
utilizing the minimum number of phases that will suffice for the clinical indication. [16]
1.1. Potential CT phases
The different phases that are possible with state-of-the-art CT scanners are myriad and include
scanning before and after contrast administration, delayed imaging, venous and arterial
phases, and several others (table 1). Specific patterns of contrast enhancement or evolution of
findings over time can dramatically aid in diagnosis in abdominal pathology, thus justifying
these additional phases in some patients. However, additional phases should only be necessary
in very specific clinical indications, and should be used judiciously as each phase will result
in additional radiation. If these additional phases are performed for a specific examination
with the same technical parameters as the original phase, which is often the case, the radiation
dose is multiplied by the number of phases making it important that the phases performed are
clinically indicated and relevant.
Phase Typical indication Timing after contrast injection
Non-contrast Identify calcifications N/A
Contrast Enhanced
Angiography Evaluate vascular anatomy 15-35 sec
Arterial
phase
Early Arterial structures 15-35 sec
Late Hypervascular tumors 15-35 sec
Portal venous phase Majority of routine imaging is
performed with this phase. Provides
excellent solid organ visualization
60-90 sec
Venous Imaging Evaluate for venous thrombosis 180 sec
Delayed Cholangiocarcinoma 10-15 minutes
Adrenal adenoma 10-15 minutes
Extravasation (i.e. active bleeding) 7-10 minutes
Renal Corticomedullary
phase
Identification of renal cortical
abnormalities
70 sec
Nephrogenic phase Characterization and improved
visualization of renal masses
100-200 sec
Excretory phase Evaluation of the renal collecting
system
10 min
Table 1. Common indications for multiphase CT
Selected Topics on Computed Tomography2
1.2. Use of multiphasic CT
Multiphase CT examinations are extremely useful in a certain subset of patients. The tempta‐
tion in a busy practice is to perform CT with a “one size fits all” approach such that physicians
will not miss the opportunity to completely characterize even the most unexpected findings.
This approach usually means utilizing multiphase scans in all patients to cover multiple
potential scenarios. Since most patients do not benefit from additional phases, this practice
results in unnecessary radiation in the majority of patients. The dose-multiplication effect of
these unnecessary phases can be dramatically reduced or eliminated with individual tailoring
of CT exams to the specific clinical scenario. [16]
In an attempt to address this issue, the American College of Radiology (ACR) has developed
evidence and expert opinion-based appropriateness criteria matching scanning protocols for
various clinical conditions. [17] Unfortunately, the criteria often do not address the most
appropriate phase for use in a specific clinical scenario, but rather allude to a “CT Abdomen
and Pelvis with IV contrast”. Therefore, identification of the most appropriate phases requires
a literature review to identify scenarios when additional phases can be expected to add
additional useful information. Our approach is to perform single phase imaging (generally the
portal venous phase) unless there is specific literature or recommendations to support
additional phases. Thus, for the indications addressed by the ACR appropriateness criteria, a
portal venous phase is the most likely recommendation. For each indication in the appropri‐
ateness criteria, the varying imaging modalities are ranked, but they generally do not discuss
the use of different phases in CT. They define 1 as being the least appropriate study for the
given indication and 9 as being the most appropriate. Similarly, the Royal College of Radiology
has also developed guidelines for the same purpose and these guidelines have many similar‐
ities to, but are not identical to the ACR guidelines [18]. For the purposes of this discussion,
we will attempt to describe utilization patterns for CT phases that are supported by the medical
literature and while these recommendations are partially based upon the ACR guidelines, we
also recommend that physicians become familiar with medical literature supporting the use
of multiphasic CT.
1.3. Indications for CT by phase
The majority of CT imaging in the head, chest and extremities are performed with single-phase
imaging and won’t be specifically addressed. However, abdominal imaging is associated with
many potential uses for multiple-phase imaging and will be discussed in detail. The majority
of abdominal and pelvic CT’s can be performed using a single-phase, but the evaluation of
some tumor types (hepatic/pancreatic/renal), the urinary collecting system, and trauma
patients among others, may be best performed with multiple phases which is described in
more detail below.
In discussing the numerous phases and indications for CT, it should be noted that best patient
care requires individualized CT protocols based upon each patient’s specific symptoms,
pathology, and underlying co-morbidities. Although labor intensive, this provides the highest
likelihood of an accurate diagnosis with the lowest necessary radiation dose. The following
discussion will provide a basic outline of current best practice, but not all clinical scenarios can
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be accounted for. Note that the ACR appropriateness criteria can be found on the ACR website
(http://www.acr.org/ac).
2. Unenhanced CT
Non-contrast CT scans Figure 1a (left) and 1b (right) are of limited use for the differentiation of
soft tissue structures. However, materials like blood, calcium (renal stones, vascular atheroscle‐
rosis), bone, and pulmonary parenchyma are highly visible and can usually be adequately
assessed with non-contrast CT. For example, in the abdomen and pelvis, there are several
indications for non-contrast imaging. These include: evaluation of renal calculi; assessment for
gross intra-abdominal hemorrhage; and post-endostent volume measurements. In addition,
non-contrast images are often obtained in conjunction with contrast enhanced images in
evaluating potential renal transplant donors and in the evaluation of the pancreas (in combina‐
tion with contrast phases). Of note, dual-energy CT and the development of virtual “non-
contrast” images may ultimately obviate the combination scans. Additionally, CT angiography
examinations performed for pathologies like aneurysms and dissection are frequently per‐
formed in conjunction with non-contrast  imaging.  The non-contrast  images facilitate  the
differentiation of active extravasation or acute bleeding from vascular calcifications.
Figure 1. Non-contrast CT demonstrating multiple bilateral renal calculi (arrows), which can be obscured on contrast-
enhanced images, particularly delayed images when there is excreted contrast in the renal collecting system; axial left,
coronal reformat on right.
3. Contrast-enhanced CT
Contrast enhanced CT examinations can be acquired at a variety of specific time points after
intravenous contrast injection (timing is dependent on the phase of contrast enhancement
Selected Topics on Computed Tomography4
needed and organ system being evaluated). The timing should be chosen specifically to
optimize contrast distribution within the solid organ parenchyma in question.
3.1. Portal venous phase
The most common technique is to perform portal venous phase imaging in the abdomen and
pelvis (approximately 60-90 seconds after contrast administration, figure 2). This results in
near optimal contrast opacification of the majority of the solid abdominal organs and it is used
for a wide variety of indications: nonspecific abdominal pain; hernia; infection; masses (with
a few exceptions such as hypervascular, renal, and some hepatic tumors); and in most follow-
up examinations. As a general rule, this single phase is adequate unless there is a specific
clinical indication that has been shown to benefit from other phases.
Figure 2. Contrast enhanced CT demonstrating parenchymal enhancement of the intra-abdominal organs in the por‐
tal venous phase (axial left, coronal reformat right).
3.2. Early arterial phase (CT Angiography (CTA))
CT angiography (CTA) is highly effective for evaluation of the arterial system, and has largely
replaced conventional angiography due to the lower risk profile and ability to survey the entire
abdomen. Images are acquired after a rapid bolus of intravenous contrast material (3-7 cc/s)
during the arterial phase (15-35 seconds after injection) when the concentration of contrast
material in the arterial system is high (figures 3). Images are usually acquired using narrow
collimation (<1 mm) and can be retrospectively reconstructed using dedicated 3-dimensional
workstations and software. CTA is commonly used in the head and chest in the evaluation of
pulmonary emboli, aneurysms, vascular malformations, dissection, bleeding and ischemia.
Indications for early arterial phase imaging include: evaluation of aneurysms or dissections
(cerebral, aortic, etc.), hepatic, splanchnic or renal arterial anatomy, and arterial imaging in
liver or kidney transplantation. Single phase arterial imaging is often used in the evaluation
of trauma patients either a complete chest/abdomen/pelvis examination with arterial phase
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imaging of the chest and portal venous phase imaging of the abdomen/pelvis or just a portal
venous phase of abdomen and pelvis depending on the mechanism and severity of the trauma.
CTA is also commonly performed in the abdomen and pelvis for evaluating vascular malfor‐
mations and in the evaluation of bleeding. Mesenteric ischemia can also be evaluated using
CT angiography. CTA of the abdomen and pelvis is often performed in combination with a
CTA for evaluating the extremity vasculature.
(a) Axial CT angiography of the 
aorta 
(b) Coronal CT 
Figure 3. Axial (left) and coronal (right) CT angiography images of the abdominal aorta evaluating for aortic aneurysm.
3.3. Late arterial phase
The late arterial phase is timed to correspond to the peak concentration of contrast material in
highly vascular tumors and is performed approximately 20-35 seconds after the injection of
intravenous contrast. Early arterial phase imaging is predominantly utilized for angiography
and will be discussed separately. Late arterial phase imaging is almost always performed in
conjunction with other phases (e.g. portal venous phase) to allow more complete characteri‐
zation of any identified abnormalities (figure 4). The primary indication for a late arterial phase
is for the evaluation of hypervascular tumors of the liver such as hepatocellular carcinoma or
hypervascular metastases (figure 4). Typical hypervascular tumors for which this would be
used include: hepatocellular carcinoma; renal cell carcinoma; melanoma; carcinoid/neuroen‐
docrine tumors; some sarcomas; choriocarcinoma; and thyroid carcinoma. Although a
“hypervascular”, biphasic evaluation would generally be used for these patients, note that a
single phase is often adequate for follow up imaging.
Selected Topics on Computed Tomography6
(a) Arterial phase (b) Portal venous phase 
Figure 4. Selected images from a biphasic CT demonstrating early arterial enhancement of a posterior right hepatic lobe
mass with mild wash out on delayed phase images in the setting of cirrhosis characteristic of hepatocellular carcinoma.
3.4. Systemic venous phase imaging
CT imaging specific for the venous structures is performed uncommonly. Most venous
structures are partially opacified on the routine contrast enhancing images and suffice for most
examinations. However, occasionally evaluation of the inferior vena cava is desired, such as
prior to IVC filter placement/removal or evaluation of IVC thrombosis.
3.5. Delayed phase
Delayed phase imaging (figure 5) encompasses scanning at a variety of different times
following contrast administration, and depends on the pathology in question. Typical delayed
imaging times range from a few minutes to up to 15 minutes or longer. The most common
indications for delayed phase imaging are evaluation of the kidneys, collecting system (ureters
and bladder) and specific kidney, liver, and adrenal tumors. [19, 20] Evaluation of the kidneys,
ureters and bladder are discussed separately in the renal imaging section. Cholangiocarcinoma
occurring within the extrahepatic biliary tree or intrahepatic cholangiocarcinomas are a
common reason for delayed imaging. Cholangiocarcinomas are fibrotic tumors which enhance
slowly, and are usually imaged following a 10-15 minute delay. Similarly, adrenal masses can
be evaluated with multiphase imaging including an unenhanced CT, portal venous phase and
a 10 minute delay CT which allows for evaluation and calculation of the enhancement and
washout characteristics aiding in distinguishing benign adrenal adenomas from other adrenal
masses.
Outside of the evaluation of masses, delayed phase images can be used in the evaluation of
active vascular extravasation in trauma patients, vascular malformations, and aneurysm
disruption.
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(a) Portal venous phase (b) Portal venous phase
Figure 5. Selected images form CT performed using a Cholangiocarcinoma specific protocol. 5a is a portal venous
phase image demonstrating a single low attenuation mass which does not appear to enhance. 5b is a 15 minute de‐
layed image which demonstrates delayed enhancement of the liver mass (arrow) characteristic of Cholangiocarcino‐
ma. Several other enhancing masses (arrowheads) are also seen which were not evident on the portal venous phase
images.
4. Organ specific considerations
4.1. Hepatic masses
When evaluating hepatic masses, it can be advantageous to have both late arterial and portal
venous phase images (biphasic imaging, figure 4) since some tumors enhance briskly during
the arterial phase (hepatocellular carcinoma, hepatic adenoma, follicular nodular hyperplasia
(FNH), and hypervascular metastasis), but may be occult or difficult to characterize on portal
venous phase imaging alone (figure 6). However, it should be stressed that the addition of late
arterial phase images is only indicated if one of these tumors is suspected, or if there is a need
for further characterization of a hepatic mass, since the large majority of patients will not
benefit from the addition of this phase. In addition, if there is a need to definitively characterize
a hepatic mass, MRI is generally more sensitive and specific, with no associated radiation dose.
4.2. Renal masses
Detection and characterization of renal parenchymal masses is a frequent indication for CT.
An initial noncontrast CT is important for detecting calcium or fat in a lesion, and to provide
baseline attenuation of any renal masses. Following noncontrast scanning, intravenous
contrast is injected and a corticomedullary phase is obtained at approximately 70 seconds
(figure 7a, 7b). The corticomedullary phase is characterized by enhancement of the renal cortex
as well as the renal vasculature. This phase is valuable in the evaluation of benign renal
variants, lymphadenopathy and vasculature, however certain medullary renal masses may
not be visible during this phase due to minimal enhancement of the medulla and collecting
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system. The parenchymal phase is obtained approximately 100-200 seconds after the injection
of contrast material (figure 7c). Parenchymal phase imaging demonstrates continued enhance‐
ment of the cortex, enhancement of the medulla, and various levels of contrast material in the
collecting system. The parenchymal phase is highly important for the detection and charac‐
terization of renal masses, parenchymal abnormalities, and the renal collecting system. [21]
This method of imaging does not evaluate for abnormalities of the collecting system.
(a) Corticomedullary phase (b) Coronal reformat of the corticomedullary phase (c) Parenchymal phase 
Figure 7. Selected images from a renal mass specific protocol CT. Corticomedullary phase (axial 7a) demonstrates pe‐
ripheral enhancement of the renal cortex with minimal opacification of the renal medulla. There is a large renal cell
carcinoma in the right kidney which can be differentiated from the normal renal parenchyma by the heterogeneous
and differential enhancement. The renal artery and vein are opacified in this phase as well. The collecting system is not
opacified (coronal reformat 7b). In the parenchymal phase, the renal cortex and the medulla are enhancing. The renal
cell carcinoma in the left kidney is not as well defined when compared to the corticomedullary phase images, but is
actually slightly more conspicuous. There is some contrast noted within the collecting system during this phase (7c).
Common renal masses can occasionally be differentiated from each other using this imaging
technique. Renal cell carcinomas and oncocytomas typically demonstrate intense heterogene‐
(a) Late arterial phase (b) Portal venous phase
Figure 6. Selected images from a biphasic CT of Focal Nodular Hyperplasia in the left hepatic lobe (arrow). These
masses have characteristic early arterial enhancement (6a) with contrast wash out on the portal venous phase images
(6b) from the mass making these lesions difficult to identify on portal venous phase images alone.
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ous enhancement on the parenchymal phase images and cannot be reliably differentiated from
each other but can be distinguished from other renal masses. Angiomyolipomas (AML’s) also
demonstrate intense contrast enhancement but characteristically contain macroscopic fat
which can be detected on the noncontrast images, and can help to differentiate AML’s from
renal cell carcinomas and oncocytomas. Renal lymphoma on the other hand, will often have
decreased enhancement when compared to the renal parenchyma on the parenchymal phase
images.
4.3. CT urography
CT urography (CTU) is commonly used in the evaluation of hematuria, and specifically
tailored to image the renal collecting system, ureters and bladder in addition to the renal
parenchyma. Initial imaging includes a noncontrast phase to detect renal calculi as a source of
hematuria. Note that dual energy CT may eventually allow the noncontrast phase to be
eliminated. Contrast enhancement techniques for CTU vary from institution to institution. A
common technique used at our institution and others is a double bolus, single phase imaging
algorithm. This technique is a hybrid contrast injection strategy that results in opacification of
the renal parenchyma (parenchymal phase, figure 8a) and the collecting system, ureters, and
bladder (excretory phase, figure 8b and 8c). At our institution, a small contrast bolus is
administered initially, followed 10 minutes later with a larger bolus that is imaged in the
corticomedullary phase. This ensures that contrast is being excreted by the kidneys and thus
the collecting system is opacified (excretory phase) from the initial injection, and that the renal
parenchyma is enhancing as well from the second injection (parenchymal phase). At the
conclusion of the urography protocol, we also perform a scout image in the supine and prone
position to allow a global evaluation of the collecting system. Excretory phase imaging allows
for not only evaluation of the ureteral lumen, but also periureteral abnormalities including
external masses and lymphadenopathy. [22]
(a) Axial Renal Parenchymal Phase (b) Coronal Format (c) Left Coronal Oblique Reformat
Figure 8. Selected images from a CT Urography protocol CT. 8a is an axial CT image from the renal parenchymal
phase. There is a mildly enhancing soft tissue mass in the left renal pelvis (arrow) consistent with a transitional cell
carcinoma. Figure 8b (coronal reformats) and 8c (left oblique coronal reformats) demonstrate the double bolus tech‐
nique of CT Urography. These images confirm soft tissue mass (arrows) in the renal pelvis with contrast excretion into
the collecting system (arrowheads).
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4.4. Pancreatic masses
Pancreatic masses are often evaluated using both an early arterial (to evaluate for vascular
involvement and thus resectability, figure 9a) and a later “pancreatic” phase (which optimizes
pancreatic parenchymal enhancement and thus is best at differentiating pancreatic tumors from
pancreatic parenchyma, figure 9b). Pancreatic adenocarcinoma typically is hypoenhancing when
compared to the surrounding parenchyma. Most other common pancreatic tumors are hypervas‐
cular with avid enhancement (such as pancreatic neuroendocrine tumors) and appear brighter
than the surrounding pancreatic parenchyma after the injection of intravenous contrast material.
(a) Noncontrast CT (b) Early arterial (c) Late arterial/pancreatic
Figure 9. Selected images from a pancreatic protocol. 9a is a noncontrast CT image demonstrating subtle fullness in
the region of the pancreatic neck (arrow). 9b is a CT image performed during the early arterial phase during which
there is opacification of the arterial structure with subtle fullness in the pancreatic neck (arrow). The pancreas is not
enhancing during this phase. 9c was performed in a late arterial/pancreatic phase demonstrating normal enhance‐
ment of the pancreas (arrowhead) with a hypoenhancing mass (arrow) in the pancreatic neck. The pancreatic mass is
more visible during this phase.
4.5. Incidental findings
CT imaging should be performed to evaluate the specific clinical question, however incidental
findings are noted in approximately 5-16 % of patients scanned for an unrelated reasons. [23,
24] It is not acceptable practice to anticipate the possibility of incidental lesions given their low
incidence and prospectively add additional phases to routine protocols. Unfortunately, several
recent surveys demonstrated that this practice is more common than might be anticipated, and
contributes to unnecessary medical radiation exposure to a large population of patients. [16]
Even more egregious is the fact that many of these findings could potentially be more accu‐
rately evaluated with other non-radiation imaging modalities such as MRI or ultrasound.
Although the management of incidental findings is not the focus of this chapter, some of these
findings will require complete characterization with further CT phases such as arterial phase
(certain liver tumors) or delayed images (adrenal lesions). Management of incidental findings
has been controversial since they are relatively common, especially in the elderly, and more
CT scanning may be required for further characterization of what is frequently a benign
finding. In an effort to provide guidance on which incidental findings should be appropriately
further evaluated and what the appropriate imaging modality should be, the ACR published
a white paper on management of incidental findings detected at CT of the abdomen in 2010. [25]
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Multiphase CT examinations are very important for the detection and characterization of
certain clinical conditions, but should not be generalized for every patient undergoing CT of
the abdomen and pelvis. A recent survey demonstrated that many physicians are routinely
performing multiphase CT for the majority of patients in an attempt to prospectively charac‐
terize potential lesions detected during the scan. However, unindicated multiphase CT
examinations are an important source of medical radiation that does not contribute to the care
of patients. Adherence to published standards such as the ACR Appropriateness Criteria can
both decrease medical radiation and optimize imaging for the specific clinical indication.
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Chapter 2
Molecular Imaging
Fathinul Fikri Ahmad Saad, Abdul Jalil Nordin,
Hishar Hassan, Cheah Yoke Kqueen and W.F.E Lau
Additional information is available at the end of the chapter
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1. Introduction
Molecular imaging techniques depend upon molecular mechanisms operative in vivo. This
imaging technique encompasses the visualization, characterization and measurement of
biological processes at the molecular and cellular levels in humans and other living systems
[1]. The techniques used include Positron Emission Tomography – Computed Tomography
(PET-CT), nuclear medicine, Magnetic Resonance Imaging (MRI), Magnetic Resonance
Spectroscopy (MRS), optical imaging and ultrasound.
There are escalating evidences in the published data that discussed the advantages of inte‐
grated molecular imaging technique as an accurate tool in localizing abnormal metabolic
alteration and serve as a potential role as an invasive surrogate biomarker for various disease
entities [2,3,4,5]. It also plays an increasingly fundamental role in drug discovery and early
development in humans. The evolution of molecular imaging tool in specific PET-CT has
impacted the use of molecular imaging technique in many altered cellular mechanism. In
particular, PET which was introduced in the 1970 s is capable of quantifying individual changes
on the different pathology that underpin the biological reprogramming in abnormal cells [6].
Intensive research activities in various PET applications gradually evolved to its clinical use
first in neuropsychiatric disorders and cardiology, then in oncology.
Molecular  imaging  provides  the  key  to  the  future  of  personalized  medicine,  which  in‐
volves diagnosing, treating and monitoring patients based on their individual makeup. The
amelioration in its technique has braced the one-stop-imaging strategy in various disease
entities as a tool for disease localization, prediction and treatment monitoring. For the purpose
of the discussion in this chapter, we highlight the integrated molecular imaging technique
PET-CT employing flurodeoxyglucose (FDG) as a standard of care utility in various disease
pathology.
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1. Introduction
Molecular imaging techniques depend upon molecular mechanisms operative in vivo. This
imaging technique encompasses the visualization, characterization and measurement of
biological processes at the molecular and cellular levels in humans and other living systems
[1]. The techniques used include Positron Emission Tomography – Computed Tomography
(PET-CT), nuclear medicine, Magnetic Resonance Imaging (MRI), Magnetic Resonance
Spectroscopy (MRS), optical imaging and ultrasound.
There are escalating evidences in the published data that discussed the advantages of inte‐
grated molecular imaging technique as an accurate tool in localizing abnormal metabolic
alteration and serve as a potential role as an invasive surrogate biomarker for various disease
entities [2,3,4,5]. It also plays an increasingly fundamental role in drug discovery and early
development in humans. The evolution of molecular imaging tool in specific PET-CT has
impacted the use of molecular imaging technique in many altered cellular mechanism. In
particular, PET which was introduced in the 1970 s is capable of quantifying individual changes
on the different pathology that underpin the biological reprogramming in abnormal cells [6].
Intensive research activities in various PET applications gradually evolved to its clinical use
first in neuropsychiatric disorders and cardiology, then in oncology.
Molecular  imaging  provides  the  key  to  the  future  of  personalized  medicine,  which  in‐
volves diagnosing, treating and monitoring patients based on their individual makeup. The
amelioration in its technique has braced the one-stop-imaging strategy in various disease
entities as a tool for disease localization, prediction and treatment monitoring. For the purpose
of the discussion in this chapter, we highlight the integrated molecular imaging technique
PET-CT employing flurodeoxyglucose (FDG) as a standard of care utility in various disease
pathology.
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2. Types of molecular imaging techniques
Molecular imaging, a new discipline in biomedical research has increasingly become a vital
tool in disease diagnostic frontier. It offers an excellent visualization, characterization and
quantification of biologic process taking place at the cellular and sub-cellular levels. As of now,
there are four main categories of molecular imaging modalities; ultrasound, optical imaging,
magnetic resonance imaging (MRI), and nuclear imaging techniques (Table 1). Bonekamp [7]
in his paper reported that the selection of the imaging modality often is determined based on
the temporal and spatial resolution, field of view, sensitivity of the imaging system, depth of
the biological process, the molecular or cellular process to image, and the availability of suitable
probes and labels than can be delivered to the imaging target. An overview of mechanism








Table 1. Types of Molecular Imaging Modalities
2.1. Ultrasound
Ultrasound imaging has been used for over 20 years. It uses high-frequency sound waves to
view soft tissues such as muscles and internal organs inside the body. As the image of the
ultrasound is captured in real-time, it enables the physician to see the movement of the body’s
internal organs as well as blood flowing through the vessels. In an ultrasound exam, a hand-
held transducer is placed against the skin. The transducer sends out high frequency sound
waves that reflect off the body structures. As sound waves directed through the body bounce
back when they encounter different tissues, echoes are measured with the help of a computer
and are converted into real-time images of organs and tissues. The image captured is based
on the frequency and strength of the sound signal and the time it takes to return from the
patient to the transducer [8].
2.2. Optical imaging
In optical imaging, light-producing proteins are designed to attach to specific molecules such
as brain chemicals or molecules on the surface of cancer cells [9]. Highly sensitive detectors
are employed for detection of low levels of light emitted by specific molecules from inside the
body. The two major types of optical imaging are bioluminescent imaging and fluorescence
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imaging. Bioluminescent imaging uses a natural light-emitting protein to trace the movement
of certain cells or to identify the location of specific chemical reactions within the body. In
contrast, fluorescence imaging uses proteins that produce light when activated by an external
light source such as laser.
2.3. Magnetic resonance imaging
Magnetic resonance imaging or popularly known as MRI is an imaging technique used mainly
in medical settings to produce high quality images of inside human body. Theoretically, the
mechanism behind MRI is based on the principles of nuclear magnetic resonance (NMR), a
spectroscopic technique used by scientist to obtain microscopic chemical and physical
information about molecules [10]. MRI scanner has a tube surrounded by a giant circular
magnet. During routine examination of MRI, patient is placed on a moveable bed that is
inserted into the magnet. The presence of magnet creates a strong magnetic field that aligns
the protons of hydrogen atoms, which are then exposed to a beam of radio waves [11]. This
spins various protons of the body, and produces a faint signal that is detected by the receiver
portion of the MRI scanner. The receiver information is processed by a computer and an image
is then produced.
2.4. Nuclear Imaging
Nuclear imaging or also called as radionuclide scanning provides an effective diagnostic tools
for the radiologists as it shows not only the structure of an organ but also the function of the
organ. Nuclear imaging routine uses small amounts of radioactive material, or tracer for
diagnostic purpose. Radioactive tracer used in nuclear imaging is normally a specifically
targeted probe. It could be antibodies, ligands or substrates to specifically interact with protein
targets in particular cells or sub cellular compartments. These interactions are based on either
receptor-radioligand binding or enzyme mediated trapping of a radio labeled substrate [12].
Radioactive tracers used in nuclear imaging are in most cases is administered into a vein and
some are given orally. After an administration of radioactive tracers, patient is required to rest
for a certain period to allow distribution of radioactive tracer in the body. In the end, for
imaging purpose, a specialized gamma camera is used to detect the radiation throughout the
body. Most commonly used techniques in nuclear imaging are positron emission tomography
(PET) and single photon emission computed tomography (SPECT).
2.4.1. Positron Emission Tomography (PET)
Positron emission tomography or known as ‘PET’ is a rapidly developing nuclear imaging
technique, with a clinical role that now exceeds almost 15 years [13].  It  is a quantitative
tomographic imaging technique which produces cross-sectional images that are composites
of volume elements [14]. The signal intensity for PET images in each voxel is dependent upon
the activity of radionuclide tagged with radioactive tracer which intravenously adminis‐
tered at the earlier stage before the scanning takes place. A scanner which usually called PET
scanner employs a gamma photon coincidence detection system designed for oppositely
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clides. This logic allows acquisition of images that are quantitative three dimensional (3-D)
maps of radiolabeled tracers in tissue. The most commonly used PET radioactive tracer is
the glucose derivative, 2-[18F]fluoro-2-deoxy-D-glucose or commercially known as [18F]FDG,
with numerous other tracers under development capable of highlighting a broad range of
organ and tissue metabolic functions. In a large meta-analysis, PET was shown to change
management in 30% of patients [15].
2.4.2. Single Photon Emission Computed Tomography (SPECT)
Similar to PET, single photon emission computed tomography (SPECT) also uses a radioactive
tracer that is administered to the patient and a scanner to record data that a computer constructs
into two or three dimensional images. However, in another note, SPECT technique employs a
gamma camera that rotates around the patient to detect a radioactive tracer in the body. In
contrast to PET which employs shorter half-lived tracers as opposed to the SPECT tracers [16].
If a tumor is present, the antibodies will stick to it and thus allow for detection of tumorous
cells. For better understanding on strength and weakness of each imaging modalities, Table
2 below provides a summary of the imaging techniques with its respective strength and
weakness.
Imaging modality Electro magnetic
radiation spectrum
Advantages Disadvantages
Ultrasound High-frequency sound Real time and low cost Limited spatial resolution, mostly
morphologic although targeted




Visible light Highest sensitivity, quick, easy,
low cost and relatively high
throughput
Low spatial resolution, current 2-D






Visible light or near-
infrared
High sensitivity, detects
fluorochrome in live and dead
cells





Radio waves Highest spatial resolution,
combines morphologic and
functional imaging
Relatively low sensitivity, long scan
and post processing time, mass





High sensitivity, shorter time scan,
enable quantitative analysis
PET cyclotron or generator









Many molecular probes available,
can image multiple probes
simultaneously, may be adapted
to clinical imaging system
Relatively low spatial resolution,
high radiation to subjects due to
longer tracer half-life’s, non-
quantitative tool,
Longer scanning time
Table 2. Key strength and weakness of the main available imaging modalities used in molecular imaging [12, 16]
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3. Integrated molecular imaging techniques (FDG PET-CT)
The astonishing achievement of the molecular imaging technique rely on its ability to signal
altered metabolism in a targeted pathological cells whereby two imaging modalities are
integrated in a single setting (multimodality imaging technique/integrated imaging) i.e. PET-
CT, SPECT-CT, PET-MRI. It includes two- or three-dimensional imaging as well as quantifi‐
cation over time (Figure 1). Largely independent of structural disturbances, integrated
molecular imaging techniques increasingly offer high spatial resolution, but more particularly,
high contrast. Minute quantities of radioactive materials, chosen because of their ability to
participate in biological processes of interest, can provide highly sensitive indications of body
function in health and disease. Therefore, disordered metabolism or physiology can be
detected with high sensitivity and the anatomical distribution of abnormality can be deter‐
mined with greater precision than the conventional technique (Table 3). The conventional
imaging techniques i.e. computed tomography (CT) or standalone nuclear medicine technique
– single positron emission tomography (SPECT) are relatively unpopular in a current scenario
given their limitations to only evaluating the structural changes or functional changes
disjointedly.
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Sensitivity versus Specificity (%)
PET-CT CT
Niikura N et al
Metastatic breast cancer[2]
97.4 versus 91.2 85.9 versus 67.3
Kim SK et al
(solitary pulmonary lesion)[3]
97.0 versus 85 93.0 versus 31.0
Pim A. et al
(malignant lymphoma)[4]
100.0versus 95.0 91.0 versus 96.0
Ozkan E et al
(colorectal cancer recurrence) [5]
98.0 versus 85.0 73.0 versus 86.0
Table 3. Data shows the accuracy of the PET-Ct and the CT in the evaluation of various tumors
3.1. FDG PET-CT and Standard Uptake Value (SUV)
The imaging of the alteration of the glucose metabolism, as reflected by cellular uptake and
trapping of the glucose analog 18F-FDG can suffice a response assessment that is both accurate
and contemporaneously than that provided by standard morphologic imaging. Quantitative
evaluation of FDG PET images provides quantitative data in the form of the standardized
uptake value (SUV). This is an uptake measurement that provides a mean of comparison of
FDG uptake between different lesions. Measurement of SUV requires attenuation correction
to avoid the variability in FDG uptake due to the differences in tumor habitus within the body.
This value normalizes the tumor FDG uptake with the FDG injected activity and the body
weight [17]. The cut-off value of 2.5 in differentiating malignant to benign is at large limited
due to varied tumor histological characteristic in malignant tumor [18)
3.2. FDG PET-CT and radiation issues
Being a glucose analogue, 2-[18F]fluoro-2-deoxy-D-glucose or commonly known as 18F-FDG,
is the most commonly used positron emitting radiopharmaceutical in PET examination. The
preparation of 18F-FDG involves the production of radioisotope fluorine-18 to tag with glucose
derivative. Fluorine-18, a positron emitters, emits gamma energy of 511 keV and due to
positron annihilation, it emits total energy of 1022 keV. This is almost 10 times higher than
conventional X-ray radiation. Therefore, it possesses high activity and dose exposure to
radiation workers and patients.
However, the radiation exposure could be outweighed due to its benefit to the patient. This is
in compliance with the International Commission on Radiological Protection (ICRP) which
recommended three elements in the system of dose limitation [19]. The three elements are;
justification, optimization and dose limitation. Justification means that any propose examina‐
tion that may cause exposure to the patients should yield a sufficient benefit to the patients to
justify the risk incurred by the radiation exposure. This element is based on the assumption
that any radiation exposure, either it is in small dose, carries with it a certain level of risk that
is proportional to the level of exposure. The second element is optimization, which is also
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known as the practice of ALARA (as low as reasonably achievable). This by all means, the
radiation exposures resulting from the examination or preparation of radiopharmaceuticals
must be reduced to the lowest level possible, considering the cost of such a reduction in dose.
The third element in ICRP recommendation is dose limitation. The dose limits are normally
imposed by the local regulatory agencies.
To accommodate a dose exposure at minimum, certain laboratory technique can be improved
when dealing with radioactive materials. The use of teleplier, long tong or robotic arms can
maximize the distance between the radioactive material and personnel. This directly reduces
the dose expose to the radiation worker [20]. In the administrative and procedure control aspect,
the introduction of automated dose dispensing will replace the manual dose dispensing activity
performs by the radiation worker to eliminate receiving of unnecessary exposure. The rota‐
tion between personnel involves in preparation of radiopharmaceutical and examination also
provides an alternative way to reduce high dose expose. Nevertheless, PET utilizes 18F-FDG as
a radiotracer carries a low absorbed dose to patient estimated at approximately 7 mSv. The
radiation (x rays) from our diagnostic CT protocol ranges from 8mSv to 16 mSv. The new
technology 64 multislice CT technique is equipped with the dual focal spot that ensures more
image yields  without  increased in the total  radiation dose.  The modulated tube current
adaptation of higher multislice CT scanner (64 and above) technique as offered by many vendors
is capable of reducing patient dose up to 20% as compared to the lower 16 multislice of the same
kind. [21,22]. In a nutshell, even though the use of molecular imaging modalities possesses risk
onto the patients and radiation workers, but the purpose of examination outweigh the implica‐
tion of the dose receive and it offers benefit for diagnosis and treatment purpose.
4. Molecular imaging in clinical application
4.1. Utility of integrated molecular imaging (PET-CT) in oncology
Oncology is now the most important application of molecular imaging techniques i.e. PET [23].
In oncology, PET can be used for signaling biological process that underpins pathological
reprogramming that  promotes  carcinogenesis.  Among the  important  signaling processes
involved are the altered glucose metabolism, amino acid metabolism, cell membranes metabo‐
lism and cell proliferation (Figure 2). Leveraging the rapidly increasing pace of technological
and scientific innovation in molecular biology, there has been a surge in the understanding of
the key drivers of malignant transformation. An important key driver in malignant transforma‐
tion is the altered glucose metabolism whereby a glucose analog or Flurodeoxyglucose (FDG)
has been utilized as a popular ligand used in labeling the tumor targets.
In vivo, intense FDG uptake and metabolism of glucose, a frequent characteristic of most cancer
cells, is associated with an alteration in the intrinsic energy metabolism causing a shift from
oxidative phosphorylation to aerobic glycolysis, a change referred to as the Warburg effect [24].
Otto Warburg, working in Germany in the 1920s, discovered that cancer cells have a character‐
istically increased glycolysis even under aerobic conditions. Because glycolysis is considera‐
bly less efficient than oxidative phosphorylation at producing adenosine triphosphate (ATP),
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natural behaviours of tumors, [18F] FDG accumulation in tumors is used as index of increased
glucose metabolism and as a marker of tumor viability for which, the degree of [18F] FDG uptake
usually reflects tumor aggressiveness. The kinetics of the FDG tracers is similar to glucose. It
passes through the brain-blood barrier and is phosphorylated intracellularly in a process
analogous to the glucose. The phosphorylized FDG compound does not enter in the Krebs cycle,
thence it is effectively trapped. FDG as a molecular marker in signifying the molecular path‐
ways of each cancer types in different types of cancer of the study. Malignant cells have increased
facilitated glucose transport and up regulation of hexokinase activity, and hence tumors can be
identified by regions of increased glucose utilization [25]. The PET tracer FDG, a glucose analog,
is used to image glucose metabolism in patients. Focal areas of abnormally increased FDG uptake
are considered suspicious for malignant disease, particularly as metabolic changes often precede
the morphological changes associated with disease. Heterogeneity of malignant cell clones in
different sites within a single tumor and between different tumor sites in the body is a manifes‐
tation of the genomic instability that characterizes cancer cells [26]. Among the indication for
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Radiation treatment planning
Development of new anticancer drugs
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4.2. FDG PET-CT in tumor localisation
By integrating two imaging modalities encompassing the structural and functional imaging
techniques, a substantial change in the treatment planning can be achieved while reduc‐
ing the cost burden and averting futile treatment to patients. Contrasted CT technique used
for the evaluation of equivocal PET results promises higher achievable diagnostic results
in the assessment of neuroendocrine tumor with prevalence brown fat accumulation. [27].
Furthermore, the details of the surrounding vitals structures are shown clearly on the co
registered contrasted CT image for appropriate correlation with the high metabolic focus
on PET [28]. The impact of PET in detecting diffuse involvement of other organ system as
part of the metastatic spread or delineation of subcentimetre focus of FDG-avidity i.e. in
melanoma has averted futile  surgery and unnecessary treatment costs (Figure 3)  [2,  29].
The combined PET-CT over scored the standalone CT and PET in the re-staging tumor after
years of free-disease survival whereby the distorted anatomy may not be easily distinguish‐
ed from the site of tumor recurrent [29]. 18[F] FDG PET-CT has been shown to be useful
for detection of  nodal  and distant metastases in patients with soft-tissue sarcomas com‐
pared with that at conventional imaging [30]
4.3. FDG PET-CT in tumor staging
The evaluation of tumor prior to any treatment or surgical intervention is vital as an inappro‐
priate staging may lead to unnecessary treatment course and cost and futile surgery. Integrated
molecular imaging technique offers a high accuracy in the staging of tumor especially those
which are equivocal on the structural imaging (CT, MRI) as correlated on the clinical back‐
ground. Metabolic information by PET is always the essential element in the determination of
an altered metabolism preceding any structural change (Figure 4). There are many published
data that support this evidence in many tumor streams. A retrospective analysis included 50
patients with 55 clinical events of elevated or increasing CEA level who underwent FDG PET-
CT and MDCT for suspected tumor recurrence, FDG PET-CT has higher sensitivity than MDCT
in the identification of sites of recurrent and metastatic disease in patients with colorectal
cancer and an elevated CEA level [31]. In a study based on 172 non small cell lung carcinoma
(NSCLC) patients from a prospective clinical study who underwent diagnostic, contrast-
enhanced helical CT and integrated PET-CT on the treatment costs, the diagnostic effectiveness
in terms of correct TNM staging was 40% (31/77) for CT alone and 60% (46/77) for PET-CT. For
the assessment of resectability (tumor stages Ia-IIIa vs. IIIb-IV), 65 of 77 patients (84%) were
staged correctly by PET-CT (CT alone, 70% [54/77]). The incremental cost-effectiveness ratios
per correctly staged patient were $3,508 for PET-CT versus CT alone [32]. Data on 122 patients
with PET-CT scans as part of their initial staging of lymphoma, PET-CT upstages 17% of cases
and detects occult splenic involvement [33]
4.4. FDG PET-CT in predicting tumor aggressiveness
In addition, the degree of metabolic defect via semi quantitative analysis, standard uptake
value (SUV) could predict tumor aggressiveness and the overall patient survival as high SUV
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important as early decision on the management strategy of a patient suffering from an advance
tumor could lead to an improved prognosis. A particular type of tumor i.e. thymoma which
their cellular make-up does not always exhibit malignant entity when a clinical assessment is
equivocally ascertained, the role of molecular imaging employing PET with glucose analog
has been shown to impact the prognostic outcome in many instances [34]. In a retrospective
study by Lopei et al of 91 patients with follicular lymphoma (FL), end-treatment PET-CT in
FL has high accuracy and appears to be a good predictor of progression free survival (PFS)
and patient outcome, irrespective of grading [35]. Due to clonal heterogeneity in some tumors,
FDG-PET could potentially become a determinant factor in determining which cells types may
be aggressive or have de-differentiated. In a study of 23 patients with neuroendocrine tumor
Figure 3. PET-CT restaging in 56-year-old man who had partial amputation of the right forearm for malignant mela‐
noma. The MIP-PET image shows innumerable hypermetabolic foci of metastatic lesion throughout the body (subcen‐
timetre lesions are imperceptible on the CT images; correlated CT image is not shown).
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(NET), Fathinul et al suggested a cut-off value of 9.1 to predict tumor with an aggressive
potential. This is in line with other study that suggests FDG-avid NET is usually more
aggressive than FDG-negative lesions whereby the former may be benefited from systemic
treatment (chemotherapy) [36]. In this regards, the role of molecular imaging is of prime
important when structural changes are lacking of certain valuable information of the tumor
altered cellular biology.
4.5. FDG PET-CT and the patient management
The use of PET-CT is potentially reported to change of the primary diagnosis in approximately
16% of cases, whereas PET-CT resulted in a change in staging and treatment plan in approxi‐
Figure 4. PET-CT Staging of recently diagnosed non-Hodgkin lymphoma by CT in 58-year-old woman. Coronal PET im‐
age shows involvement of the spleen (CT image was normal; correlated image is not shown) for which the disease was
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mately 28% to 32% of the cases, respectively (Table 5) [37]. One area in which FDG PET can
play a significant role is in establishing response to treatment [38]. Current procedures to
monitor therapy use mainly anatomical imaging modalities, such as CT, even though meta‐
bolic changes in tumors may occur earlier than, or even instead of, anatomical size changes.
A significant metabolic change can be established by comparing uptake values from pre- and
post treatment scans, although such comparisons can only be made accurately on attenuation-
corrected, quantitative PET images.
Patient (P) Histological Diagnosis AJCC (6th ed) Staging before
PET-CT Scan
AJCC (6th ed) Staging after
PET-CT Scan
P1 NPC Stage III Stage IVB
P2 NPC Stage IVB Stage IVB
P3 Ca larynx Stage I Stage I
P4 Sarcoma of tonsil Stage II
P5 Metastatic papillary carcinoma of thyroid NA Stage I
P6 Occult node-Metastatic carcinoma of neck NA FDG uptake only in
Lymph nodes
P7 Primary adnexal Ca Stage I Stage I
P8 Ca larynx Stage I Stage I
P9 Thyroglossal cyst with focal papillary
carcinoma
NA Stage III
P10 NPC Stage II Stage IVA
P11 NPC Stage I Stage I
P12 NPC Stage III Stage IVA
P13 Ca tonsil Stage IV Stage IVB
P14 Lymphoma Stage I Stage III
P15 NPC Stage I Stage I
P16 Metastatic adenocarcinoma of base of skull NA Stage IVC
P17 Ca hard palate Stage II Stage IVC
P18 NPC Stage III Stage IVB
P19 NPC Stage II Stage IVC
P20 NPC Stage II Stage IVA
P21 NPC Stage III Stage IVC
P22 NPC Stage III Stage IVC
P23 NPC Stage I Stage IVC
Table 5. Data of 23 patients with head and neck tumors on the disease staging before and after the PET-CT evaluation
(39)
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5. FDG PET-CT as a predictor of overall patient survival
The use of FDG as a ligand in particular for a molecular imaging technique i.e. PET-CT has
been shown to provide prognostic stratification. The complete metabolic response of tumor as
imaged on the FDG-PET-CT scan implies a favourable change in tumor apoptosis which is
correlated with good prognosis. In a study by Fathinul et al focusing on the esophageal tumor
as group-staged by I–IIA and IIB–IV had a 1-year survival of 50% and 25% respectively [40].
Patient with size of primary tumor (<4.5cm) had significantly (p< 0.036) better survival than
those with large size (>4.5cm). A SUVmax of > 5.5 in the primary tumor [Hazard Ratio (HR)
58.65; 95% confidence interval, p=0.032] and presence of FDG-avid lymph node (HR 20.83; p =
0.010) were strongly predictive of poor overall survival on multivariate analysis Figure (5)
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6. FDG-PET-CT in coronary artery disease
Cardiovascular disease is one of the leading causes of death. It carries great impact on the
patients, their families as well as the country socially and financially. Cardiology is also a
rapidly advancing field, with new approaches to prevention, risk stratification, diagnosis and
treatment. Early detection and appropriate risk stratification will help to optimize resources
and to ensure that appropriate treatment will be provided to those who would benefit from
it. Diagnostic methods commonly used in the detection and risk stratification of coronary
artery disease include exercise stress testing, stress echocardiography, multi-slice computed
tomography, Single Photon Emission Computed Tomography (SPECT) and invasive coronary
angiography. Each of these modalities has its own advantages, disadvantages and limitations.
The management of coronary artery disease includes lifestyle modifications, medications,
percutaneous coronary interventions and coronary artery bypass surgery. Invasive procedures
carries risks, as well as its associated costs, thus it is imperative that proper selection of patients
are made based on the clinical presentation and the results of investigations. Positron Emission
Tomography is a relatively new diagnostic modality with the potential to address some of the
limitations of current commonly used diagnostic methods. Cardiology imaging using Inte‐
grated PET-CT equipment demonstrates an improved method in detecting abnormal coronary
circulation. The resolution of PET-CT images are superior than SPECT imaging as a result of
improved camera resolution and specification, high energy positron captured and CT attenu‐
ation corrected in all PET data acquisition.
In PET, 18F-FDG is the tracer most frequently used to assess myocardial viability (41-43). Since
FDG is a glucose analogue, the substance is used to evaluate cardiac glucose utilization where
mitochondria plays pivotal role in its utilization. The initial uptake in myocardial tissue is
comparable to glucose uptake. After phosphorylation, 18F FDG-6-PO4 is trapped within
cardiac tissues and the metabolism ends before the Krebs cycle enabling imaging due to the
strong signal from radiation source emitted by 18-F isotope.
Evaluation of residual glucose metabolism, a hallmark of viable myocardium, by FDG –PET
is considered the most sensitive non-invasive tool to assess the myocardial viability[ 44-45].
Viable myocardium shows preserved FDG uptake whereas, markedly reduced or absent
uptake indicates scar tissue formation (Figure 6-7). Most studies relate myocardial perfusion
to the FDG PET viability. FDG accumulates in the myocytes independent of the vascular
enrichment. Therefore quantitative assessment of the FDG concentration in the myocardium
is vital as it indicates viable tissue which is amenable to be reversed [46].
Integrated PET-CT system can be utilized in myocardial perfusion study using 82-Rubidium
(Figure 8). The dynamic data acquisition during rest and stress are quantifiable using dedicated
coronary flow quantification software (47-49). Abnormal readings will be obtained in coronary
obstruction and endothelial dysfunction using this method. Myocardial flow reserve quanti‐
fication has high sensitivity and positive predictive value in correlation with left ventricular
function (Figure 9). Thus, can be recommended as a suitable non invasive tool in making
clinical decision for managing patients with coronary artery disease
Selected Topics on Computed Tomography28
7. FDG PET-CT in infection
FDG is a well known in-vivo biomarker indicating the rate of tissue metabolism. The initial
course of direction for clinical utility of PET-CT in oncology is now widened into the field of
infections [50-52]. Increase cancer tissue metabolism are thought to be related to raised in
surrounding inflammatory reaction as demonstrated by Kubota resulting from high accumu‐
Figure 6. The transaxial non-gated static SPECT image (1st and 2nd rows from the top) and PET-CT image (3rd and 4th
rows). There is a reversible defect seen affecting the posterior wall of left ventricle which filled up during FDG PET-CT
study in keeping with a reversible ischaemic myocardial segment.
Figure 7. The horizontal long axis non-gated static SPECT image (1st and 2nd rows from the top) and PET-CT image (3rd
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lation of macrophages and granulation tissues [53]. Likewise, in infection, initial increased in
local hyperemia and capillary permeability will lead to aggregation of granulocytes, leucocytes
and macrophage at the point of entry by pathogens. This cascade of events will lead to
increased in local glucose consumption. The signals from annihilation process of positively
charged beta particles emitted from radioactive fluorinated glucose molecules in-situ will be
detected by PET camera during PET-CT imaging where the activity can be semi-quantified
using the semi-quantitative uptake value (SUV). The SUV of infective foci are often raised
above the background 18F-FDG soft tissue activity.
Despite their known clinical entity, the use of 18F-FDG PET-CT in establishing the diagnosis
of infection and inflammatory condition is still controversial. A meta analysis conducted
[54-62] from a series of review articles found that 18F-FDG demonstrate highest utility in cases
of chronic osteomyelitis, hip prostheses, diabetic foot, fever of unknown origin, vasculitis,
Figure 8. Myocardial perfusion 82-Rb demonstrating high quality images in a normal patient.
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acquired immunodeficiency syndrome, and vascular graft infection. The role of CT during
integrated PET CT imaging in the diagnosis of these conditions may range between CT for
anatomical correlation and attenuation correction to non attenuation corrected fused images.
In some condition, informations obtained from CT which may be classical and pathognomonic
can be an important adjunct features in deciding clinical management.
For example, PET using 18F-FDG appears to be a highly sensitive method in detecting infective
foci in the bone. Histologically, the 18F-FDG avidity defines the area of fibroblast proliferation
and neovascularisation with mononuclear cell infiltration at the granulation tissue formation
whereby these cells utilises most of their energy from the trapped 18F-FDG for cells metabolism
[63-65]FDG-PET is sensitive than the standalone CT in delineating evidence of implant
infection (Figure 10)
However, since artefact through beam hardening effect of X-ray from CT scan during PET-CT
study can significantly obscure the underlying pathology, often non attenuation corrected
images are being the standard reference in making clinical decision for major interventional
procedure. Thus, a combined PET-CT study can be a very useful modality in solving painful
hip problem in a patient with hip prosthesis.
18F-FDG PET-CT can also be a useful technique in ruling out infection in critically ill patients
under Intensive Care Unit (ICU) management. Study has shown that a normal scan exclude
prolonged use of antibiotic in these patients [66]. Combined CT and PET have also been
Figure 9. Quantification analysis of 82Rb Myocardial Perfusion PET CT study of a young man demonstrating normal
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whereby these cells utilises most of their energy from the trapped 18F-FDG for cells metabolism
[63-65]FDG-PET is sensitive than the standalone CT in delineating evidence of implant
infection (Figure 10)
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Figure 9. Quantification analysis of 82Rb Myocardial Perfusion PET CT study of a young man demonstrating normal




reported to be useful in detecting vascular prosthesis infection. The presence of infection in
such cases usually in elderly, will justify for removal of infected prosthesis. More recently,
Rudd et al disclosed the capability of 18F-FDG-PET-CT in identifying and quantifying vascular
inflammation within atherosclerotic plaques [67].These vulnerable plagues carry high risk of
auto detachment causing embolisation and ischaemic infarct to vital organs increasing the risk
for cerebral vascular accident and ischaemic heart disease (Figure 11). Positive correlation
between FDG uptake measurements in the left anterior descending artery with high risk factors
of coronary artery diseases has been established [68].
The scope of FDG PET-CT study is widest in cancer imaging leading to increasing application
of this powerful modality into clinical practice. There has been significant evidence showing
non exclusivity of FDG as a tumor marker observed with increase FDG uptake seen in a wide
range of infection and inflammatory conditions[69]. Examples are chronic granulomatous
infections like sarcoidoses, infections by tuberculosis, fungal infection like aspergillosis and
narcoidoses which are known to demonstrate high FDG uptake. Although they can jeopardize
the accuracy of integrated imaging interpretation in malignancy, their high standardized
uptake value (SUV) during semiquantification on FDG PET-CT can be exploited and utilized
as an important localizing tool for guided biopsy and potentially useful for navigating
response to treatment [70].
8. FDG PET-CT in pre-clinical application
PET/SPECT neuroreceptor and metabolic imaging, as well as conventional and functional MR
imaging, MR spectroscopy, optical imaging, and other techniques, is utilized almost routinely
to help establish proof of- mechanism studies for new drugs, especially at the interface between
Figure 10. Coronal CT (left panel) is insensitive in delineating implant infection as the FDG PET-CT (right panel) is clear‐
ly showing increased FDG uptake along the implant denoting underlying infection (arrow heads).
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preclinical and early phase 1 studies. In particular the use of FDG as a PET probe, its SUVmax
values have been shown to correlate with histologic grade in heterogeneous series of bone and
soft-tissue sarcomas [71]. The potential for molecular imaging in small animals to increase
knowledge of drug effects in models of human cancer has been recognized around the world.
This has been embraced as a means of decreasing the time taken to indentify agents that merit
clinical trial and to decrease the cost of drug development [72]. The ability to extrapolate from
animals to human studies makes PET a logical technique for both pre-clinical testing of new
therapeutic drugs and for the validation of new tracers that might be relevant to the evaluation
of human diseases. Manipulation of cells and tissues to produce animal models that mimic
human diseases provides a useful system to test new tracers. At a pragmatic level, a short
feedback loops between studies in mice and then in man is important. While unrestrained
proliferation has been described as a hallmark of cancer and is a target of several targeted anti-
cancer therapeutics, due to differences in blood thymidine levels and in the metabolism of PET
probe which look at cell proliferation i.e. Fluorothymidine (FLT), both uptake and excretion
of this tracer show significant differences in biodistribution in different species.
9. FDG PET-CT in non-clinical application
The development of imaging technologies, including hybrid systems allow the evaluation of
gene expression in various cancers. The underlying original genetic problems of cancer can be
Figure 11. Cross sectional image of abdominal aorta demonstrating vulnerable plague at 11 o’clock (SUVmax of 3.3)
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monitored by PET using radiolabeled metabolic substances including glucose, amino acids or
nucleotides. Sometimes, molecular imaging means genetic imaging or molecular-genetic
imaging in which the assessment is based on the reporter genes and labeled antisense oligo‐
nucleotide probes [73].
Radiolabeled antisense oligonucleotide probes have been applied to image endogenous gene
expression at the transcription level [74]. In diagnostic radiology, CT and ultrasonography
(US) have been examined as means of molecular-genetic imaging. In PET, dopamine 2 receptor
(D2R) gene is used as an imaging reporter gene, because of the availability of the well estab‐
lished radiolabeled probe 18F-fluoroethlspiperone (FESP) [75]. Moreover, Furukawa et al. [76]
have designed a reporter gene imaging system based on 18F-labeed estradiol and human
estrogen receptor ligand (hERL) binding domain in access of various tissues for gene therapy
monitoring.
Several researchers have investigated the use of γ-emitters for molecular imaging [77, 78];
examples include the somatostatin receptor (SSTr) 2 (SSTr2) gene and 111Inoctreotide [79], the
norepinephrine transporter gene and 131I-labeled metaiodobenzylguanidine (131I-MIBG) [80],
sodium/iodide symporter (NIS) gene and radioiodines or 99mTc-pertechnetate [33, 34]. Jacobs
et al. [81] demonstrated the first human PET image of HSV1-tk gene expression in a glioma
patient.
10. Molecular imaging: Future perspective
Molecular imaging is now being accepted by many (physicians) as an important platform in
translating genetic defect through aberrant protein function and cellular transformation and
development. Nevertheless, the sensitivity of molecular imaging techniques is varied depend‐
ing on the type of radiopharmaceutical marker used in signaling the biological processes. In
particular, the use of FDG as a ligand PET-CT has many limitations. The most obvious example
of this is in the brain where high glucose utilisation by the normal cerebral cortex can mask
brain tumors, particularly those of well differentiated. In addition, some tumors with high
metastatic potential can have relatively low FDG-uptake. Similarly, the specificity of FDG–
PET is also imperfect with some benign conditions, particularly granulomatous lesions i.e.
tuberculosis, having high FDG uptake. These very real limitations of FDG used in the molec‐
ular imaging technique have enticed the search for alternative radiotracers which signal
different biological disease process. Several alternative PET-radiopharmaceuticals are cur‐
rently being investigated, which have the potential to reveal the proliferation rate, oxygen
utilization, drug resistance properties and the viability of the tumors. Examples of new PET
tracers include fluoroethyltyrosine (FET) for brain tumor imaging; the proliferation marker
18F-fluorothymidine (FLT) to assess bone marrow reserves and the exploitation of dual tracer
strategy i.e. FDG and 68 Ga DOTA –octreotate for staging and therapeutic response in
neuroendocrine tumor would promise a more complete assessment of disease process and
tumor biology. The choline analogue 18F-fluorocholine (FCH) for patients with rising prostate
specific antigen levels would potentially have an impact on the management strategy and thus
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improve the overall patient survival. It is likely that the continuing success of molecular
imaging will rest on the future development of more disease specific ligand or tracer, used in
specific combination to answer the important clinical question.
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1. Introduction
Today most hospitals use PACS systems locally to store and evaluate picture data produced
by various modalities (i.e. x-ray, ultrasound, computer tomography, etc.).
Outsourcing of archiving and communication technology offers a place for cooperation among
hospitals and for utilization of the existing multimedia data on patients. This approach changes
the thinking of medical specialists and teaches them to cooperate and share data on patients.
Gradually, it changes the thinking of medical specialists and gets them to cooperate and share
data about patients in electronic form. It builds a network of medical specialists. The impact
of this project is not only in patient care but also in the education of medical specialists. Some
data (e.g. typical cases of given disease) stored in the MeDiMed PACS archive can be anony‐
mized (i.e. personal data of patients is replaced by fictitious data) and used for educational
purposes.
In the following chapters we briefly recall basic principles of the PACS and introduce the
MeDiMed project.
1.1. PACS
The PACS (Picture Archiving and Communications System) is a currently used procedure and
methodology for processing medical multimedia data obtained from picture acquisition
machines like x-ray, ultrasound or computer tomography. Medicine picture data obtained
from these machines (in PACS terminology called modalities) are stored in central PACS
server. The PACS server then provides these multimedia data to viewing stations. Viewing
stations serve for the radiologists to analyze and evaluate the multimedia data. This approach
offers much more capabilities than former film medium. Viewing stations allow image
transformation, combination of images from more modalities etc. National Electrical Manu‐
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facturers Association (NEMA) has developed a standard for communications between
modalities, PACS servers and viewing stations. This standards is DICOM [3]. Currently
DICOM version 3.0 is used in mostly all modalities and PACS servers. The structure of PACS
is cleanly presented on the Figure 1.
Figure 1. Common structure of PACS system. Modalities serve for acquisition of medicine multimedia data. These data
are stored in PACS server and examined and analysed in viewing stations.
The digital processing of medicine multimedia data is very cost effective comparing to the
legacy film based approach. A good example is the price comparison between a teleconsulta‐
tion and a scenario where a doctor has to drive to visit a patient. The advantages of the
telemedicine activities compared to the traditional methods are as follows:
• sharing of images among the cooperating institutions and their departments;
• cooperation with foreign medical partners;
• external long-term archiving of image data;
• management of other information associated and processed with image data;
• cost-benefit analysis performed by radiologists on standby duty at home;
• possibilities of functional integration of radiology departments of more healthcare institu‐
tions; and,
• integrating medical imaging with the concept of an electronic patient record.
Deep theoretical background of PACS principle and into basic protocol DICOM is discussed
in [1] and [2]. Brief technical introduction to the PACS system architecture is in [4,6,8].
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Utilization of computer based medicine image processing brings new capabilities to the
healthcare. Picture data can be processed and evaluated remotely in a reasonable time now.
This approach allows to quickly ask for opinion of top specialists in case of a rare diseases
diagnostics and ask for a second opinion or second reading in case where the radiologist is
unsure.
1.2. MeDiMed project
Today most hospitals are using local PACS system serving only to one hospital. The goal of
the MEDIMED project [7,10,11] is to initialize collaboration among hospitals as far as archiving
and use of medical multimedia data and to provide the necessary technological infrastructure.
The Shared Regional PACS project MeDiMed started as a collaborative effort among Brno
hospitals to process medical multimedia data. Masaryk University is the coordinator of this
project ensuring that the demands and requirements of radiology departments are met,
overseeing the changing legislative standards and the practical limitations of technology.
Masaryk University, in cooperation with CESNET Association, also provides the necessary
networking infrastructure.
Additionally, the project is to create conditions for general access to medical imaging data. The
data exists already but its use is limited both in scope and time. By better utilization of the
already existing equipment the project will bring a new quality into the healthcare operative,
medical education and medical research as well as the decision-making on the level of local
authorities.
The system deals with transmitting, archiving, and sharing medical image data originating
from various medical modalities (computer tomography, magnetic resonance, ultrasound,
mammography, etc.) from hospitals in the Brno metropolitan area. The Central PACS serves
as a metropolitan communications node as well as a long term archive of patient's image
studies.
Rather than creating just a computer network, it builds a network of medical specialists. This
work not only impacts the healthcare field but also the education of medical specialists. The
data stored in the shared archive can be made anonymous (i.e. personal data of patients is
replaced by fictious data) and used for educational purposes.
Moreover, the process of making the data anonymous can be done in such a way that the data
on a real patient obtained from several hospitals uses the same anonymous identity. That offers
the students a more complex view of the evolution of the patient's health.
The realization of the project facilitates fast communication among individual hospitals, allows
decision consultations, and brings various other advantages due to direct connections via optic
networks. In general the MediMed project is clearly designed to support society-wide
healthcare programs in the Czech Republic as well as programs implemented by other
countries. The system is also supposed to serve as a learning tool for medical students of the
Masaryk University as well as physicians in hospitals.
MEDIMED Shared Regional PACS Center — Case Study
http://dx.doi.org/10.5772/55904
45
facturers Association (NEMA) has developed a standard for communications between
modalities, PACS servers and viewing stations. This standards is DICOM [3]. Currently
DICOM version 3.0 is used in mostly all modalities and PACS servers. The structure of PACS
is cleanly presented on the Figure 1.
Figure 1. Common structure of PACS system. Modalities serve for acquisition of medicine multimedia data. These data
are stored in PACS server and examined and analysed in viewing stations.
The digital processing of medicine multimedia data is very cost effective comparing to the
legacy film based approach. A good example is the price comparison between a teleconsulta‐
tion and a scenario where a doctor has to drive to visit a patient. The advantages of the
telemedicine activities compared to the traditional methods are as follows:
• sharing of images among the cooperating institutions and their departments;
• cooperation with foreign medical partners;
• external long-term archiving of image data;
• management of other information associated and processed with image data;
• cost-benefit analysis performed by radiologists on standby duty at home;
• possibilities of functional integration of radiology departments of more healthcare institu‐
tions; and,
• integrating medical imaging with the concept of an electronic patient record.
Deep theoretical background of PACS principle and into basic protocol DICOM is discussed
in [1] and [2]. Brief technical introduction to the PACS system architecture is in [4,6,8].
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Utilization of computer based medicine image processing brings new capabilities to the
healthcare. Picture data can be processed and evaluated remotely in a reasonable time now.
This approach allows to quickly ask for opinion of top specialists in case of a rare diseases
diagnostics and ask for a second opinion or second reading in case where the radiologist is
unsure.
1.2. MeDiMed project
Today most hospitals are using local PACS system serving only to one hospital. The goal of
the MEDIMED project [7,10,11] is to initialize collaboration among hospitals as far as archiving
and use of medical multimedia data and to provide the necessary technological infrastructure.
The Shared Regional PACS project MeDiMed started as a collaborative effort among Brno
hospitals to process medical multimedia data. Masaryk University is the coordinator of this
project ensuring that the demands and requirements of radiology departments are met,
overseeing the changing legislative standards and the practical limitations of technology.
Masaryk University, in cooperation with CESNET Association, also provides the necessary
networking infrastructure.
Additionally, the project is to create conditions for general access to medical imaging data. The
data exists already but its use is limited both in scope and time. By better utilization of the
already existing equipment the project will bring a new quality into the healthcare operative,
medical education and medical research as well as the decision-making on the level of local
authorities.
The system deals with transmitting, archiving, and sharing medical image data originating
from various medical modalities (computer tomography, magnetic resonance, ultrasound,
mammography, etc.) from hospitals in the Brno metropolitan area. The Central PACS serves
as a metropolitan communications node as well as a long term archive of patient's image
studies.
Rather than creating just a computer network, it builds a network of medical specialists. This
work not only impacts the healthcare field but also the education of medical specialists. The
data stored in the shared archive can be made anonymous (i.e. personal data of patients is
replaced by fictious data) and used for educational purposes.
Moreover, the process of making the data anonymous can be done in such a way that the data
on a real patient obtained from several hospitals uses the same anonymous identity. That offers
the students a more complex view of the evolution of the patient's health.
The realization of the project facilitates fast communication among individual hospitals, allows
decision consultations, and brings various other advantages due to direct connections via optic
networks. In general the MediMed project is clearly designed to support society-wide
healthcare programs in the Czech Republic as well as programs implemented by other
countries. The system is also supposed to serve as a learning tool for medical students of the
Masaryk University as well as physicians in hospitals.
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The gradual development of the joint system for processing and archiving image information
is a natural step towards an increasing health care standard in the city of Brno and the whole
region. Information on a patient's treatment in his own healthcare center as well as in other
centers would be available. Consultations by more specialists will be enabled over the patent's
picture, in case that a required specialist is not available in the center in question. Image
information evaluation can be carried out in another place, general practitioners in the country
will be able to consult specialists in hospitals, etc. Examination results will be available for the
doctors in much shorter time than before. The implementation of the project has increased the
speed of communication among individual hospitals, allowed decision consultations, and
brought various other advantages due to dedicated network connections.
The realization of the project facilitates fast communication among individual hospitals, allows
decision consultations, and brings various other advantages due to direct connections via optic
networks. In general, the MeDiMed project is clearly designed to support common healthcare
programs in the Czech Republic as well as programs implemented by other countries. The
system is also supposed to serve as a learning tool for medical students of the Masaryk
University as well as physicians in hospitals.
More detailed description of regional PACS system MeDiMEd and it step-by-step develop‐
ment is available in [4-6,8,12-14].
2. Technology used in MeDiMed
Medical picture data like X-Ray, CT, US, MR, etc. cannot be used without additional informa‐
tion like picture data description or evaluation, diagnosis, possibly a reference to the history
of a patient's health, previous treatments and other information relevant to the patient. This
complex set of information about a patient represents a very sensitive data.
Therefore high level of security for medical image data maintained by the regional PACS
archive has to be provided. We have to secure the data in three stages: data stored on servers
of the regional PACS, data transported over the network between this archive and the user,
and users' access to these data.
The security of the data stored on the regional PACS servers is achieved by using dedicated
hardware for this application and by strict limitation of the access (both physical and network
based) to this equipment.
The security of the data transported over the network is provided by using dedicated fibre
optics lines when available and by employing strong cryptography (IPSEC with AES-256
encryption algorithm) on all lines which are shared with other data traffic.
The main principle of the hospital-to-MeDiMed connection is the use of two firewalls. One of
them is in front of the MeDiMed PACS servers and is under the control of the MeDiMed staff.
The second one is the hospital's firewall and is controlled by the hospital staff. It allows us, as
administrators of the application, to control the access to central resources and allows the
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administrators of the hospital's network to control the access to the hospital’s network. That
way all participants have the access to the network they are responsible for under their control.
This principle applies to all types of connections (dedicated fiber optics or IPSEC tunnel)
between the MeDiMed servers and the hospital. The structure is easy to see from Figure 2.
Figure 2. Common principle of the hospital to MeDiMed connection. There are two firewalls on the path form modali‐
ties and viewing stations to the PACS server. One of them is controlled by hospital and the second on by university.
Image distribution by specially configured dedicated computer networks plays a key role in
the implementation of telemedicine. Every particular component of the whole system is
certified so it can be integrated into the hospital information system infrastructure of cooper‐
ating healthcare institutions. All software tools are strictly based on the DICOM standard and
could be easily incorporated into the already running systems.
The technology and networking solutions used in MeDiMed will be described in the following
chapters.
2.1. Connections based on dedicated fibre optics
There is a large fibre optic cable network owned and operated by the universities in the city
of Brno. The development of this network started in 1993. The ownership of the physical
communication infrastructure is the key point for development and deployment of advanced
networking services. MeDiMed is a good example of such a service.
The network is based on a fiber optic cable. Both, terrestrial and above ground, types of cable
are used. The optical lines mostly have a ring topology for better reliability. This network
interconnects all universities in the city and their faculties spread around whole city, various
institutes of the Academy of Science, local government, courts, mostly all hospitals and some
other institutions which were "on the road". Currently the network consists of about 150 km
of optical cables and more than 90 nodes are using it.
The ownership of the private fiber optic network with enough free optics is mandatory for the
implementation of new applications. It offers the freedom to establish private connections
dedicated to these applications.
The development of computer networks is very fast as far as both the technology and the needs
of network users are concerned. Since the beginnings of the Internet, full of enthusiasm of users
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The gradual development of the joint system for processing and archiving image information
is a natural step towards an increasing health care standard in the city of Brno and the whole
region. Information on a patient's treatment in his own healthcare center as well as in other
centers would be available. Consultations by more specialists will be enabled over the patent's
picture, in case that a required specialist is not available in the center in question. Image
information evaluation can be carried out in another place, general practitioners in the country
will be able to consult specialists in hospitals, etc. Examination results will be available for the
doctors in much shorter time than before. The implementation of the project has increased the
speed of communication among individual hospitals, allowed decision consultations, and
brought various other advantages due to dedicated network connections.
The realization of the project facilitates fast communication among individual hospitals, allows
decision consultations, and brings various other advantages due to direct connections via optic
networks. In general, the MeDiMed project is clearly designed to support common healthcare
programs in the Czech Republic as well as programs implemented by other countries. The
system is also supposed to serve as a learning tool for medical students of the Masaryk
University as well as physicians in hospitals.
More detailed description of regional PACS system MeDiMEd and it step-by-step develop‐
ment is available in [4-6,8,12-14].
2. Technology used in MeDiMed
Medical picture data like X-Ray, CT, US, MR, etc. cannot be used without additional informa‐
tion like picture data description or evaluation, diagnosis, possibly a reference to the history
of a patient's health, previous treatments and other information relevant to the patient. This
complex set of information about a patient represents a very sensitive data.
Therefore high level of security for medical image data maintained by the regional PACS
archive has to be provided. We have to secure the data in three stages: data stored on servers
of the regional PACS, data transported over the network between this archive and the user,
and users' access to these data.
The security of the data stored on the regional PACS servers is achieved by using dedicated
hardware for this application and by strict limitation of the access (both physical and network
based) to this equipment.
The security of the data transported over the network is provided by using dedicated fibre
optics lines when available and by employing strong cryptography (IPSEC with AES-256
encryption algorithm) on all lines which are shared with other data traffic.
The main principle of the hospital-to-MeDiMed connection is the use of two firewalls. One of
them is in front of the MeDiMed PACS servers and is under the control of the MeDiMed staff.
The second one is the hospital's firewall and is controlled by the hospital staff. It allows us, as
administrators of the application, to control the access to central resources and allows the
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administrators of the hospital's network to control the access to the hospital’s network. That
way all participants have the access to the network they are responsible for under their control.
This principle applies to all types of connections (dedicated fiber optics or IPSEC tunnel)
between the MeDiMed servers and the hospital. The structure is easy to see from Figure 2.
Figure 2. Common principle of the hospital to MeDiMed connection. There are two firewalls on the path form modali‐
ties and viewing stations to the PACS server. One of them is controlled by hospital and the second on by university.
Image distribution by specially configured dedicated computer networks plays a key role in
the implementation of telemedicine. Every particular component of the whole system is
certified so it can be integrated into the hospital information system infrastructure of cooper‐
ating healthcare institutions. All software tools are strictly based on the DICOM standard and
could be easily incorporated into the already running systems.
The technology and networking solutions used in MeDiMed will be described in the following
chapters.
2.1. Connections based on dedicated fibre optics
There is a large fibre optic cable network owned and operated by the universities in the city
of Brno. The development of this network started in 1993. The ownership of the physical
communication infrastructure is the key point for development and deployment of advanced
networking services. MeDiMed is a good example of such a service.
The network is based on a fiber optic cable. Both, terrestrial and above ground, types of cable
are used. The optical lines mostly have a ring topology for better reliability. This network
interconnects all universities in the city and their faculties spread around whole city, various
institutes of the Academy of Science, local government, courts, mostly all hospitals and some
other institutions which were "on the road". Currently the network consists of about 150 km
of optical cables and more than 90 nodes are using it.
The ownership of the private fiber optic network with enough free optics is mandatory for the
implementation of new applications. It offers the freedom to establish private connections
dedicated to these applications.
The development of computer networks is very fast as far as both the technology and the needs
of network users are concerned. Since the beginnings of the Internet, full of enthusiasm of users
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and their happiness when the network was running at least sometimes we have moved
through decades of manifold bandwidth raising (64 kbps was considered very good 15 years
ago, today 100 Mbps is considered substandard) up to current state when a high performance
internet connectivity is a standard. The users' demand for reliability has grown at a similar
ratio.
In the beginning of the development of our network we used 10 Mbps Ethernet, mostly on a
multimode fiber. At that time it was an economically acceptable solution corresponding with
the level of technology of that time. In 1995 we started to use ATM because of the need for
more bandwidth as well as the need for a dedicated transport channel for special applications.
Today ATM is outdated in the area of data communication. However, at the time when FDDI
was no longer a perspective technology and Fast Ethernet was not yet standardized, it was a
reasonable solution. Both Ethernet and ATM network were built as a common open network
of Masaryk University, Brno University of Technology and other academic parties. The ATM
technology was the first one offering enough bandwidth and enough privacy to be able to
support medicine multimedia data transport.
After the ATM age the networking technology moved to gigabit and ten-gigabit ethernet. This
technology offers enough bandwidth and necessary services for a reasonable price. The second
main change is the concept of an interconnection of the various institutions inside the metro‐
politan network. Terms like firewall and network security were not very common in the
beginning of the Internet. Mail relays were open for everybody etc. At that time individual
nodes of the metropolitan network were interconnected without any regard for the adminis‐
trative structure. The main criterion was technical and economical availability. With the
development of the Internet, the principles of solidarity and academic cooperation have
gradually been ignored. The Internet has become an everyday part of our lives and not
everybody respects the privacy of the participating institutions. Contemporary networks are
built in such a way that every institution makes a compact unit ensuring security from
unwanted activity of other Internet users.
The application of medical multimedia data transport was constructed as an isolated and
closed network. Only two hospitals with only one type of modality (ultrasound) were
interconnected in the first stage via the ATM network. This interconnection was created as an
ATM LANE network and a private IP address space was used. Step by step, more hospitals
and more types of modalities have been connected. As far as technology is concerned, we have
moved from ATM LANE to the private Fast Ethernet based on dedicated fiber optic pairs. A
necessary prerequisite for this was the development of private fiber optic network. A dedicated
fibre optics line can be dedicated to demanding applications as the private fibre optics cables
contain enough free lines.
2.2. Encrypted tunnels
For hospitals along the scope of our fiber optics network we need to use dedicated lines leased
from anybody who can offer it (very expensive solution) or public data network. The use of
the public data network is more economical but it enforces utilization of strong cryptography
for securing the data. IPSEC with AES-256 encryption algorithm is used for this purpose. The
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basic principle is kept as depicted on Figure 2. Typical interconnection of his type is on Figure
3.
Figure 3. Connecting the hospital via IPSEC tunnel
2.3. Alien wavelength across the cesnet DWDM network
CESNET is an association originated by universities and Academy of science of Czech republic
in 1996. Its main goal is to operate and develop academic backbone network of Czech republic.
This network has started on lines with bandwidth in hundreds of kbps and step by step has
grown to current backbone based on combination of ten-gigabit ethernet an even hundred
gigabit etherent. The target speed of the core backbone is 100Gbps for the upcomming two
years. The CESNET backbone interconnected all academic cities in republic.
CESNET provides services to education and research community. For research projects the
budget is usually limited and the demand for special networks services (high bandwidth, low
latency, certain level of privacy etc.) is very high. CESNET is a member of European research
organisations like GEANT and is participating in a lot of research project in computer
networks.
The CESNET backbone network is based on leased dark fiber lines enlighted by CESNET
equipment. This is so called Custommer Empowered Fiber (CEF) approach. Dark fibre
provides a lot of advantages and CESNET is using this technology on all backbone lines.
DWDM technology is used in the core of the network. DWDM is used to provide data channels
going through several backbone nodes. The real length of data channel may be several
hundreds of kilometres. More detailed description of the CESNET backbone networks and
technology solutions used to operate it is described in [16 – 19].
DWDM transport networks is traditionally used by service providers to offer clear channel
services to its customers. Customers signal is typically carried as "gray" signal from customer's
equipment to provider's equipment. This signal is inside transponder converted into "col‐
oured" one and transported across DWDM providers network.
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and their happiness when the network was running at least sometimes we have moved
through decades of manifold bandwidth raising (64 kbps was considered very good 15 years
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internet connectivity is a standard. The users' demand for reliability has grown at a similar
ratio.
In the beginning of the development of our network we used 10 Mbps Ethernet, mostly on a
multimode fiber. At that time it was an economically acceptable solution corresponding with
the level of technology of that time. In 1995 we started to use ATM because of the need for
more bandwidth as well as the need for a dedicated transport channel for special applications.
Today ATM is outdated in the area of data communication. However, at the time when FDDI
was no longer a perspective technology and Fast Ethernet was not yet standardized, it was a
reasonable solution. Both Ethernet and ATM network were built as a common open network
of Masaryk University, Brno University of Technology and other academic parties. The ATM
technology was the first one offering enough bandwidth and enough privacy to be able to
support medicine multimedia data transport.
After the ATM age the networking technology moved to gigabit and ten-gigabit ethernet. This
technology offers enough bandwidth and necessary services for a reasonable price. The second
main change is the concept of an interconnection of the various institutions inside the metro‐
politan network. Terms like firewall and network security were not very common in the
beginning of the Internet. Mail relays were open for everybody etc. At that time individual
nodes of the metropolitan network were interconnected without any regard for the adminis‐
trative structure. The main criterion was technical and economical availability. With the
development of the Internet, the principles of solidarity and academic cooperation have
gradually been ignored. The Internet has become an everyday part of our lives and not
everybody respects the privacy of the participating institutions. Contemporary networks are
built in such a way that every institution makes a compact unit ensuring security from
unwanted activity of other Internet users.
The application of medical multimedia data transport was constructed as an isolated and
closed network. Only two hospitals with only one type of modality (ultrasound) were
interconnected in the first stage via the ATM network. This interconnection was created as an
ATM LANE network and a private IP address space was used. Step by step, more hospitals
and more types of modalities have been connected. As far as technology is concerned, we have
moved from ATM LANE to the private Fast Ethernet based on dedicated fiber optic pairs. A
necessary prerequisite for this was the development of private fiber optic network. A dedicated
fibre optics line can be dedicated to demanding applications as the private fibre optics cables
contain enough free lines.
2.2. Encrypted tunnels
For hospitals along the scope of our fiber optics network we need to use dedicated lines leased
from anybody who can offer it (very expensive solution) or public data network. The use of
the public data network is more economical but it enforces utilization of strong cryptography
for securing the data. IPSEC with AES-256 encryption algorithm is used for this purpose. The
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basic principle is kept as depicted on Figure 2. Typical interconnection of his type is on Figure
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Figure 3. Connecting the hospital via IPSEC tunnel
2.3. Alien wavelength across the cesnet DWDM network
CESNET is an association originated by universities and Academy of science of Czech republic
in 1996. Its main goal is to operate and develop academic backbone network of Czech republic.
This network has started on lines with bandwidth in hundreds of kbps and step by step has
grown to current backbone based on combination of ten-gigabit ethernet an even hundred
gigabit etherent. The target speed of the core backbone is 100Gbps for the upcomming two
years. The CESNET backbone interconnected all academic cities in republic.
CESNET provides services to education and research community. For research projects the
budget is usually limited and the demand for special networks services (high bandwidth, low
latency, certain level of privacy etc.) is very high. CESNET is a member of European research
organisations like GEANT and is participating in a lot of research project in computer
networks.
The CESNET backbone network is based on leased dark fiber lines enlighted by CESNET
equipment. This is so called Custommer Empowered Fiber (CEF) approach. Dark fibre
provides a lot of advantages and CESNET is using this technology on all backbone lines.
DWDM technology is used in the core of the network. DWDM is used to provide data channels
going through several backbone nodes. The real length of data channel may be several
hundreds of kilometres. More detailed description of the CESNET backbone networks and
technology solutions used to operate it is described in [16 – 19].
DWDM transport networks is traditionally used by service providers to offer clear channel
services to its customers. Customers signal is typically carried as "gray" signal from customer's
equipment to provider's equipment. This signal is inside transponder converted into "col‐
oured" one and transported across DWDM providers network.
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Price of transponder is a mandatory part of the overall cost of DWDM service we've tried to
use DWDM gigabit ethernet pluggable modules instead. The cost of these DWDM pluggables
is several times lower than the price of corresponding transponder. The transponder provides
more than just "colouring" of customers signal. It also ensures proper signal power. The length
of the fiber line from transponder to the DWDM multiplex itself is usually few tens of
centimetres. In case of utilisation of "coloured" custommers‘ signal the length of corresponding
fiber span is typically several kilometres or tens of kilometres. The fiber optics line between
customer and provider will introduce some attenuation of the signal. We have performed a
set of lab measurements to learn the minimal input signal level of customer's DWDM signal
that can ensure enough OSNR and guarantied BER. The eye diagrams from these testing are
presented on Figure 4 just for better overview.
The first application of alien wavelength technology in CESNET was connection of Faculty
Thomayers hospital in Prague to the MeDiMed PACS archive in Brno.
Figure 4. The eye diagram of signal used for testing of DWDM connection for Faculty Thoamyers’ Hospital. The signal
on the upper figure is clear signal generated by ten-gigabit ethernet pluggable module. The bottom figure is the
weakest yet fully usable signal. Pictures are taken from [19].
Selected Topics on Computed Tomography50
2.4. Wireless and satelite connections
As already mentioned, the backbone system uses optical wires as a transport medium.
Nevertheless, only the hospitals in the city and several of the others in the republic are
connected by optical wires.
Another transport medium which is being used is the radio connection. It may be utilized for
the main connection of the locality, however in that case the bigger hospitals require at least
20-30 Mbit/s speed. We are speaking mainly about sending and storing pictures from MR, CT,
and similar modalities where there is a high demand for transport capacity.
Fixed wireless connection is often used as the first mile of the hospital‘s connection to the
public  data network.  We have optical  connections between cities,  but  the fixed wireless
connection is needed to connect the hospitals inside the city. This concerns establishing traffic
in the paid band.
One of the biggest groups of the users of the wireless networks are the radiologists. They very
frequently use the opportunity to create the descriptions of the pictures at home. That way,
they may react to urgent cases immediately. There is no need to go to hospital and start working
on a pressing case after a significant delay. Simultaneously, they save their time, because the
work on the picture may often take significantly less of it, than the voyage.
Another technology, which we use for the MediMed project, is the satellite. Within the scope
of HEALTHWARE project (which is a 6th EU framework program project), there are being
installed terminal satellite devices to the places, where any proper connections are not existent.
Some facilities, such as medical institutions for patients with tuberculosis, may be found in
woodlands, areas without industrial burden. Than, the usage of a satellite system is one of the
few ways, we may use for transfer of a medical information. It is therefore used despite its
limited data capacity, that is so needed in the cases of urgent demands for transfer and
processing of medical image data.
2.5. Mobile users
By scaling PACS outside of single hospital we meet with some limitations of DICOM protocol.
DICOM was designed to be used inside one hospital. Inside one hospital where everything is
under one common administration there is not necessary to have strong authentication
mechanism. DICOM can identify its users only by IP address of the user’s viewing station. In
collaborative environment spread across more hospitals it may happen that the given medicine
specialist needs to use more than one viewing station and vice versa the given viewing station
is used by more specialists. Every medicine specialist should have access to different collections
of patients picture data.
PACS users authentication in heterogenous environment (like regional PACS archive is) it is
rather complicated. Lets recall most common cases of PACS usage.
First kind of PACS users are medicine modalities (X-Rays, CT, MR, etc.). Modalities are
producing medicine picture data and storing it into PACS archive. Modalities have got a fixed
IP address and a limited set of communication and authentication capabilities. From computer
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Price of transponder is a mandatory part of the overall cost of DWDM service we've tried to
use DWDM gigabit ethernet pluggable modules instead. The cost of these DWDM pluggables
is several times lower than the price of corresponding transponder. The transponder provides
more than just "colouring" of customers signal. It also ensures proper signal power. The length
of the fiber line from transponder to the DWDM multiplex itself is usually few tens of
centimetres. In case of utilisation of "coloured" custommers‘ signal the length of corresponding
fiber span is typically several kilometres or tens of kilometres. The fiber optics line between
customer and provider will introduce some attenuation of the signal. We have performed a
set of lab measurements to learn the minimal input signal level of customer's DWDM signal
that can ensure enough OSNR and guarantied BER. The eye diagrams from these testing are
presented on Figure 4 just for better overview.
The first application of alien wavelength technology in CESNET was connection of Faculty
Thomayers hospital in Prague to the MeDiMed PACS archive in Brno.
Figure 4. The eye diagram of signal used for testing of DWDM connection for Faculty Thoamyers’ Hospital. The signal
on the upper figure is clear signal generated by ten-gigabit ethernet pluggable module. The bottom figure is the
weakest yet fully usable signal. Pictures are taken from [19].
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Nevertheless, only the hospitals in the city and several of the others in the republic are
connected by optical wires.
Another transport medium which is being used is the radio connection. It may be utilized for
the main connection of the locality, however in that case the bigger hospitals require at least
20-30 Mbit/s speed. We are speaking mainly about sending and storing pictures from MR, CT,
and similar modalities where there is a high demand for transport capacity.
Fixed wireless connection is often used as the first mile of the hospital‘s connection to the
public  data network.  We have optical  connections between cities,  but  the fixed wireless
connection is needed to connect the hospitals inside the city. This concerns establishing traffic
in the paid band.
One of the biggest groups of the users of the wireless networks are the radiologists. They very
frequently use the opportunity to create the descriptions of the pictures at home. That way,
they may react to urgent cases immediately. There is no need to go to hospital and start working
on a pressing case after a significant delay. Simultaneously, they save their time, because the
work on the picture may often take significantly less of it, than the voyage.
Another technology, which we use for the MediMed project, is the satellite. Within the scope
of HEALTHWARE project (which is a 6th EU framework program project), there are being
installed terminal satellite devices to the places, where any proper connections are not existent.
Some facilities, such as medical institutions for patients with tuberculosis, may be found in
woodlands, areas without industrial burden. Than, the usage of a satellite system is one of the
few ways, we may use for transfer of a medical information. It is therefore used despite its
limited data capacity, that is so needed in the cases of urgent demands for transfer and
processing of medical image data.
2.5. Mobile users
By scaling PACS outside of single hospital we meet with some limitations of DICOM protocol.
DICOM was designed to be used inside one hospital. Inside one hospital where everything is
under one common administration there is not necessary to have strong authentication
mechanism. DICOM can identify its users only by IP address of the user’s viewing station. In
collaborative environment spread across more hospitals it may happen that the given medicine
specialist needs to use more than one viewing station and vice versa the given viewing station
is used by more specialists. Every medicine specialist should have access to different collections
of patients picture data.
PACS users authentication in heterogenous environment (like regional PACS archive is) it is
rather complicated. Lets recall most common cases of PACS usage.
First kind of PACS users are medicine modalities (X-Rays, CT, MR, etc.). Modalities are
producing medicine picture data and storing it into PACS archive. Modalities have got a fixed
IP address and a limited set of communication and authentication capabilities. From computer
MEDIMED Shared Regional PACS Center — Case Study
http://dx.doi.org/10.5772/55904
51
science or networking point of view modalities are particular devices witch special commu‐
nication requirements and should be served with respect to their natural properties. These
devices may be used by authorised personell only and security of data provided by these
equipments is guarantied by restricting physical access to these devices for authorised staff
only.
Dedicated viewing stations are special working places which serve for evaluation of picture
data obtained from modalities. This evaluation is performed by radiologiests or another
medicine specialists who are trained and sklilled specially for evaluation of medicine picture
data. These specialists should have access to all images obtained from modalities because they
are responsible for picture data interpretaion. Picture data description provided by radiolog‐
iests is in next step used by other medicine specialists for diagnosis assesment and treatment
of patient. Radiologists need a specialised hardware for proper work. From computer per‐
spective this hardware can be identified by its IP address. This type of identification is sufficient
to authorise radiologist access to given medicine picture.
Physicians - experts in various branches of medicine - represent the most complicated part of
PACS users. Given physician should have access only to data concerning his patients,
sometimes patients of his department and in some special cases given patients of other
physicians. By special cases we mean first of all consultations asked by personal physician of
given patient. Physicians typically can access the PACS system from more than one computer
(from working place, from home or some times from other department of hospital). On the
other hand given computer may be shared by several physicians especially in case of special‐
ised stations with graphics capabilities customised for viewing images from X-ray or other
particular modality. For this group of PACS users we have to provide proper authentication
mechanism.
The only authentication mechanism common to all used versions of DICOM is the IP address.
In case of modalities and viewing stations used by radiology deparment for medicine pictures
evaluation this is appropriate solution. We decided to use IP addresses also for authentication
of all other PACS users. Of course general IP address of workstation cannot be used as an user
identity. Pretty good solution seems to be utilisation of some properties of IPSEC.
In this case the user is authenticated by his publis RSA key. After successfull authentication
an IPSEC tunnel is established between users workstation and dedicated IPSEC server used
by regional PACS. IPSEC server then assignes tunnel IP address to the user's station. User
authentication in the PACS system is then based on the tunnel IP address.
PACS users identity is based on PKI infrastructure. Each user who needs to use more than one
station or who is sharing viewing staions with others will be provided by an USB dongle
containing his private RSA key. The key is generated on the dongle and never leaves it. So it's
really very difficult for anybody else then the authorised user to use it. The corresponding
public key is signed by regional PACS certification authority. A dedicated certification
authority is used at this moment. The problem of electronic identity of physicians should be
solved globally for the whole healthcase system in the future.
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2.6. Redundancy
The key services of the regional PACS system are running in two distinct locations. The
MeDiMed services can provide better reliability and availability this way. MeDiMed is able to
survive the failure of any single fibre optics line, server, storage, electricity (though it is backed
up via UPS and motor-generator) in one location and even a failure of the PACS system
software in one location. The global view on this system is illustrated on Figure 5.
Figure 5. Detail of MeDiMed redundant infrastructure.
Networking infrastructure offers redundant connectivity for both local and remote hospitals.
For local hospitals there are two independent fibre optics lines. One line connects the hospital
to the primary location and the second one to the backup location. Remote hospitals utilize
IPSEC tunnels also connected to both locations. The critical single point of fail for them is the
connection to public data network. This connection is usually unprotected.
The MeDiMed project utilises a lot of servers for many different applications. For all applica‐
tions provided to the MeDiMed users we have to offer a reliable enough service.
There is a set of PACS servers used for a routine storage of medical images. The PACS server
for this type of service runs on a dedicated hardware in both university sites used by MeDiMed.
Primary and backup PACS servers servicing the given hospital or providing given particular
service work as two standalone and mostly independend servers. Data from the primary server
are replicated to the backup one via DICOM protocol. One site is a primary site and, until it
fails, all images are stored on this location. The second site serves as a backup location and all
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science or networking point of view modalities are particular devices witch special commu‐
nication requirements and should be served with respect to their natural properties. These
devices may be used by authorised personell only and security of data provided by these
equipments is guarantied by restricting physical access to these devices for authorised staff
only.
Dedicated viewing stations are special working places which serve for evaluation of picture
data obtained from modalities. This evaluation is performed by radiologiests or another
medicine specialists who are trained and sklilled specially for evaluation of medicine picture
data. These specialists should have access to all images obtained from modalities because they
are responsible for picture data interpretaion. Picture data description provided by radiolog‐
iests is in next step used by other medicine specialists for diagnosis assesment and treatment
of patient. Radiologists need a specialised hardware for proper work. From computer per‐
spective this hardware can be identified by its IP address. This type of identification is sufficient
to authorise radiologist access to given medicine picture.
Physicians - experts in various branches of medicine - represent the most complicated part of
PACS users. Given physician should have access only to data concerning his patients,
sometimes patients of his department and in some special cases given patients of other
physicians. By special cases we mean first of all consultations asked by personal physician of
given patient. Physicians typically can access the PACS system from more than one computer
(from working place, from home or some times from other department of hospital). On the
other hand given computer may be shared by several physicians especially in case of special‐
ised stations with graphics capabilities customised for viewing images from X-ray or other
particular modality. For this group of PACS users we have to provide proper authentication
mechanism.
The only authentication mechanism common to all used versions of DICOM is the IP address.
In case of modalities and viewing stations used by radiology deparment for medicine pictures
evaluation this is appropriate solution. We decided to use IP addresses also for authentication
of all other PACS users. Of course general IP address of workstation cannot be used as an user
identity. Pretty good solution seems to be utilisation of some properties of IPSEC.
In this case the user is authenticated by his publis RSA key. After successfull authentication
an IPSEC tunnel is established between users workstation and dedicated IPSEC server used
by regional PACS. IPSEC server then assignes tunnel IP address to the user's station. User
authentication in the PACS system is then based on the tunnel IP address.
PACS users identity is based on PKI infrastructure. Each user who needs to use more than one
station or who is sharing viewing staions with others will be provided by an USB dongle
containing his private RSA key. The key is generated on the dongle and never leaves it. So it's
really very difficult for anybody else then the authorised user to use it. The corresponding
public key is signed by regional PACS certification authority. A dedicated certification
authority is used at this moment. The problem of electronic identity of physicians should be
solved globally for the whole healthcase system in the future.
Selected Topics on Computed Tomography52
2.6. Redundancy
The key services of the regional PACS system are running in two distinct locations. The
MeDiMed services can provide better reliability and availability this way. MeDiMed is able to
survive the failure of any single fibre optics line, server, storage, electricity (though it is backed
up via UPS and motor-generator) in one location and even a failure of the PACS system
software in one location. The global view on this system is illustrated on Figure 5.
Figure 5. Detail of MeDiMed redundant infrastructure.
Networking infrastructure offers redundant connectivity for both local and remote hospitals.
For local hospitals there are two independent fibre optics lines. One line connects the hospital
to the primary location and the second one to the backup location. Remote hospitals utilize
IPSEC tunnels also connected to both locations. The critical single point of fail for them is the
connection to public data network. This connection is usually unprotected.
The MeDiMed project utilises a lot of servers for many different applications. For all applica‐
tions provided to the MeDiMed users we have to offer a reliable enough service.
There is a set of PACS servers used for a routine storage of medical images. The PACS server
for this type of service runs on a dedicated hardware in both university sites used by MeDiMed.
Primary and backup PACS servers servicing the given hospital or providing given particular
service work as two standalone and mostly independend servers. Data from the primary server
are replicated to the backup one via DICOM protocol. One site is a primary site and, until it
fails, all images are stored on this location. The second site serves as a backup location and all
MEDIMED Shared Regional PACS Center — Case Study
http://dx.doi.org/10.5772/55904
53
data are automatically copied from the master servers to the backup servers. The backup
servers are available at all times for retrieving of medical images in the read-only mode. This
way the overall performance of the system can be improved. If the master site fails we can
manually switch the backup site to the read-write mode and the former master site to the read-
only mode. In many cases the primary and the backup PACS servers are from different
vendors. Even though, bidirectional synchronisation of the PACS servers is more complicated
in this case. The manual switching of primary and backup PACS servers provides good enough
service with regards to the number of failures. Moreover, modalities have some local cache so
that they can keep images for several days. Older images are available for reading on both
primary and backup sites.
Another large set of PACS servers are so called communication PACS servers. That means
PACS servers used for an interchange of medical images between healthcare institutions.
Unlike the PACS servers used for routine storage of medical images, the communication PACS
servers have to be switched automatically. Communication PACS retrieves the image from
one client and offers it to another one. Clients have to manually switch to backup communi‐
cation PACS server in case of failure of the primary one.
We have considered a cluster of two hardware servers, preferably located in two different sites
of the network. Even though this solution seems to be popular, well known and tested, it is
not suitable for PACS servers used in MeDiMed. The utilisation of hardware clusters needs
some basic support from applications. Hardware failure may occur at any time and any stage
of data processing, especially at any stage of storing the data into the database or simply writing
the data into the disk subsystem. The time granularity of copying the raw image from a master
to a slave system more or less corresponds to the heartbeat frequency. In the case of the master
to slave switching we may lose data processed since the last heartbeat tick to the failure of the
master system. The application should assume such situation and enclose the critical opera‐
tions into transactions to allow recovery from the master hardware failure. Most communica‐
tion PACS servers used in MeDiMed do not expect to run in a cluster environment.
2.7. InstantPACS system
Small healthcare institutions and private doctor’s offices are being more and more equipped
with diagnostics devices like CT X-ray ultrasound etc. The small healthcare institutions
demand for medicine picture data processing capabilities and services is coming right now.
MeDiMed intends to offer PACS services also to these new perspective medicine users. The
specific property of PACS or any ICT services in small healthcare institution is lack of technical
staff capable to solve issues on place. For this reason we are developing an ”all-in-one” device
which will serve as local PACS server for the healthcare institution and provide backup and
communication services. Development and deployment of such a system is coved by the
InstantPACS project.
The aim of the InstantPACS project is to develop a maintenance-free PACS system suitable for
small and midsized healthcare institutions. This PACS system will offer to the small healthcare
institutions a user amenity obvious in hospitals including e.g. automatic backup of medicine
data. The most important properties of this system are user friendliness, maintenance free
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operations and pricing acceptable for private doctor’s offices. The InstantPACS project is an
integral part of the MeDiMed shared regional PACS server overlay project.
InstantPACS is remotely controllable and from point of view of users is not asking for any
local maintenance. General user of the InstantPACS will be private doctor’s office. A private
doctor’s office is typically equipped with an ultrasound and one or two more modalities like
CT. Modalities in private doctor’s office are from point of view of data communication isolated
devices. Data from these modalities are usually transported on a USB sticks or processed locally
on the modality’s console. It is necessary to interconnect modalities and viewing stations in
the doctor’s office to offer medical picture processing comfort usual in large hospitals. Once
the data will be transported from the modality outside it is necessary to provide at least the
following services:
• transport data to the viewing station
• backup the data to an external device or PACS system
• long term archive of the data
• prevent any unauthorized access to the data
• allow to share data between authorized users
The InstantPACS server is used in a very similar manner like PACS systems in large hospitals.
Of  course  there  are  some technology  discrepancies  given  by  different  server  placement
possibilities in large hospitals (dedicated computer room with air conditioning enough space
etc.) and private doctor’s offices (one room shared by treatments and server hosting, room
temperature  etc).  These  worst  environmental  conditions  have  introduced  some  Instant‐
PACS server hardening demands. Backup of medicine picture data from Instant PACS server
will be performed on two backup PACS servers located at Masaryk University. The data
communication  will  be  performed  over  Internet  via  two  tunnels  protected  by  strong
cryptography used as shown on Figure 6.
The key requirement is no or as small as possible regular local maintenance of the system.
Users of the InstantPACS are expected to have no or very little experience with management
of servers operating systems etc. On the other hand we expect rather large number of users.
All critical events and states should be automatically detected and reported. Also some
extensions of the installed system like addition of new modality (which is typically performed
by trained ICT staff in large hospitals) should be solvable in an intuitive way.
The hardware platform used for InstantPACS is based on off-the-shelf components and was
tailored especially to this project. It has dedicated memory for system software and configu‐
ration and redundant disk subsystem for storage of medicine picture data. It can contain
embedded ethernet switch to connect few modalities in a typical private doctor’s office. IPSEC
tunnels for backup data encryption are terminated directly in the InstantPACS so no additional
equipment is needed.
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2.7. InstantPACS system
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with diagnostics devices like CT X-ray ultrasound etc. The small healthcare institutions
demand for medicine picture data processing capabilities and services is coming right now.
MeDiMed intends to offer PACS services also to these new perspective medicine users. The
specific property of PACS or any ICT services in small healthcare institution is lack of technical
staff capable to solve issues on place. For this reason we are developing an ”all-in-one” device
which will serve as local PACS server for the healthcare institution and provide backup and
communication services. Development and deployment of such a system is coved by the
InstantPACS project.
The aim of the InstantPACS project is to develop a maintenance-free PACS system suitable for
small and midsized healthcare institutions. This PACS system will offer to the small healthcare
institutions a user amenity obvious in hospitals including e.g. automatic backup of medicine
data. The most important properties of this system are user friendliness, maintenance free
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operations and pricing acceptable for private doctor’s offices. The InstantPACS project is an
integral part of the MeDiMed shared regional PACS server overlay project.
InstantPACS is remotely controllable and from point of view of users is not asking for any
local maintenance. General user of the InstantPACS will be private doctor’s office. A private
doctor’s office is typically equipped with an ultrasound and one or two more modalities like
CT. Modalities in private doctor’s office are from point of view of data communication isolated
devices. Data from these modalities are usually transported on a USB sticks or processed locally
on the modality’s console. It is necessary to interconnect modalities and viewing stations in
the doctor’s office to offer medical picture processing comfort usual in large hospitals. Once
the data will be transported from the modality outside it is necessary to provide at least the
following services:
• transport data to the viewing station
• backup the data to an external device or PACS system
• long term archive of the data
• prevent any unauthorized access to the data
• allow to share data between authorized users
The InstantPACS server is used in a very similar manner like PACS systems in large hospitals.
Of  course  there  are  some technology  discrepancies  given  by  different  server  placement
possibilities in large hospitals (dedicated computer room with air conditioning enough space
etc.) and private doctor’s offices (one room shared by treatments and server hosting, room
temperature  etc).  These  worst  environmental  conditions  have  introduced  some  Instant‐
PACS server hardening demands. Backup of medicine picture data from Instant PACS server
will be performed on two backup PACS servers located at Masaryk University. The data
communication  will  be  performed  over  Internet  via  two  tunnels  protected  by  strong
cryptography used as shown on Figure 6.
The key requirement is no or as small as possible regular local maintenance of the system.
Users of the InstantPACS are expected to have no or very little experience with management
of servers operating systems etc. On the other hand we expect rather large number of users.
All critical events and states should be automatically detected and reported. Also some
extensions of the installed system like addition of new modality (which is typically performed
by trained ICT staff in large hospitals) should be solvable in an intuitive way.
The hardware platform used for InstantPACS is based on off-the-shelf components and was
tailored especially to this project. It has dedicated memory for system software and configu‐
ration and redundant disk subsystem for storage of medicine picture data. It can contain
embedded ethernet switch to connect few modalities in a typical private doctor’s office. IPSEC
tunnels for backup data encryption are terminated directly in the InstantPACS so no additional
equipment is needed.
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Figure 6. Common principle of InstantPACS communication with the centralized PACS servers.
2.8. Monitoring
The amount of various equipments used in MeDiMed is increasing during MeDiMed devel‐
opment and new functionalities deployment. The amount of used equipment and the increa‐
sind demand for reliability and availability of MeDiMed services enforced development of
centralised monitoring system. This monitoring system provides all the necessary supple‐
mental services like collecting of traffic statistics, networking devices configuration backup,
time synchronisation, network administrators authentication, etc.
Two Linux based servers are used as central management stations. These servers are working
independently and are located at both of the MeDiMed centrall locations. The primary
management station is located at the Institute of Computer Science of Masaryk University and
the second one is located at the Faculty of Medicine. Each management station provides full
set of services. Monitoring servers form a redundant solution for all the goals listed above.
Both of the monitoring servers are running Nagios. Nagios is a popular open source software
platform. It is widely used to network component status, servers CPU utilisation and number
of running processes, disk storage utilization and many others.
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The whole monitoring system is accessible via web interface and provides the current status
as well as the history of all equipments and services availability. Critical alarms are propagated
via SMS messages distributed via SMS Siemens 35i terminals directly connected over RS232
interface to both management servers.
The monitoring servers are collecting syslog messages as well. Syslog messages are parsed and
processed on daily basis. The resulting file provides both statistics of stored medical image
studies, DICOM pictures provided by separate modalities and errors encountered by all PACS
servers. This summary result is distributed via e-mail daily.
It is very useful to have remote access to console interfaces of both servers and networking
devices especially for emergency cases. A set of KVM (Keyboard-Video-Mouse) switches are
used in both primary and backup locations for this purpose. KVM switches offer remote access
via web interface. Dedicated Cisco routers are used to connect those KVM switches to the data
network. These routers also provide access to console interfaces of networking equipment via
reverse telnet. Access to KVM switches and other console ports from outside of the dedicated
MEDiMEd wolrd is permitted only via IPSEC tunnels ended directly on the above mentioned
routers. This approach provides us emergency secure access to management interfaces of all
key equipments.
3. Benefit of cooperation in medicine
Many PACS installations are only limited to the scope of a particular radiology department or
work as a repository of a single modality. An effective usage of that technology means image
distribution at least throughout the whole healthcare institution. However, the most promising
approach for exploiting of PACS technology is to use it at the regional or national level and to
support the associated medical processes that way.
By effective usage is meant not only basic support of daily routines in radiology departments
but also the support of distant consultations, digital long-term archiving and development of
shared knowledge databases for research and education.
MeDiMed project brings a new quality into healthcare, medical education and medical
research as well as the treatment decision-making.
3.1. Cooperation on the area of medicine picture data processing
The is a set of so called communications PACS servers inside the MeDiMed. Communication
PACS server means PACS server used for interchange of medicine images between healthcare
institutions. Communications PACS subsystem allows medicine specialist to share the picture
data for diagnosis consultations second reading or even load balancing of radiologists.
The MeDiMed platform supports the cooperation it the area of processing of medical image
information also in international scale. For example the Healthware (Standard and interoper‐
able satellite solution to deploy health care services over wide areas) project within the sixth
framework programme of EU covers many telemedicine activities.
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PACS server means PACS server used for interchange of medicine images between healthcare
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data for diagnosis consultations second reading or even load balancing of radiologists.
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The goal of the Healthware project is developing of healthcare services over the satellite
network to increase quality and comfort in European medical practices. The aim is to bridge
the medical digital divide in Europe by designing, integrating and validating interoperable
telecoms and services platforms to provide existing and future healthcare services. The satellite
based platforms can interact with mobile and terrestrial technologies to supply effective and
reliable end-to-end healthcare services and boost the deployment of large-scale satellite
communications telemedicine services.
Additionally, Healthware will have a beneficial effect on training and education as far as 7
Universities and Research Centres are concerned. For undergraduate, post-graduate and PhD
students, the participation in such programs is a unique opportunity to be exposed to team
work with regular reporting and evaluation by the partners. The research performed is usually
of very high quality due to the number experts involved in the group and the concentration
of financial resources. It is also the occasion to be exposed to a multicultural environment and
to establish international relationships that are very useful to build and strengthen the
European Research Area.
3.2. Medical training support
Teaching has always been one of the most important parts of radiology. The fundamental
principle is very simple. Every radiology department participating in teaching of medical
students or in research is equipped with specialized diagnostic workstation. This workstation
must be primarily connected to their hospital PACS system or other equipment generating
image studies in DICOM format.
Images appropriate for teaching and research purposes are made anonymous (i.e. the personal
data of the patient and other information that may disclose the patient’s identity is replaced
by fictitious information) when sending into Educational and Research PACS. One of the basic
principles when sending images into the Educational and Research PACS is the coordinated
assignment of fictitious patient identity, so it can offer a more complex view of the evolution
of the patients health in situations where the patient is being treated in different healthcare
facilities. Therefore, the legal barrier preventing access to sensitive and confidential patient
data is removed.
The database of anonymized CT images is populated by senior medicine specialists. It is used
by medicine students and by novice medicine doctors as well.
The education superstructure consists of Case Study objects. Every Case Study object is
hypertext document describing given medical case and referencing relevant anonymized
medical image studies. Case Study is accessible via standard www browser and if there is
specialized diagnostic viewer installed on this computer then referenced image can be
manipulated and processed appropriate way using all possibilities supported by particular
viewer. It means that students of medical faculties could access huge amount of interesting
systematized medical image information related to their subject from their teaching rooms.
Teaching room equipped with appropriate software can also serve as trainer for young
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radiologists. This way they can learn new technologies, compare hardware and software of
different diagnostic workstations.
The core of our solution is tailored PACS. That PACS can be used as a "PACS trainer" for
students and young radiologists but also forms the basis for additional educational and
research applications such as for example the Case Studies describing treatment of real
patients. The Case Study is an integrated hypertext document forming didactic unit and
consists of short texts, structured clinical data, radiological images of various kinds, images
from nuclear medicine modalities, macroscopic and microscopic pathology images or dem‐
onstration of the video movies recorded during surgeries.
The Case Study can be accessible via standard web browser and if the users have DICOM
diagnostic workstation installed on their computers, then the referenced image study can be
manipulated and processed in all ways supported by the particular workstation. It means that
medical students can access large amounts of systematized medical cases related to their
subject. The labs equipped with appropriate software can also serve as training simulators for
those training to be radiologists. The students can learn more practical lessons instead of
wasting their time in the library.
Every image study must be annotated with a detailed description in DICOM Structured Report
format and every image must also be assigned a set of key words describing all the medical
findings and diagnosis for better retrieval of specific cases. Data on the real patient obtained
from several hospitals uses the same fictitious identity, thereby offering students a more
complex view of the evolution of the patient's health.
Educational and Research PACS solution also supports utilization of sets of key words making
a search for specific image studies easier. An automatic evaluation of answers regarding
prepared collections of images that are not described, used for medical students' examination
purposes, etc. and provide an additional benefit.
4. Conclusion
The MeDiMed project has started a deeper collaboration among hospitals in the area of
processing of medical multimedia data and to provide the necessary technological infrastruc‐
ture for this cooperation. Additionally, the project created conditions for general access to
medical imaging data.
The implementation of the MeDiMed project facilitates fast communication among individual
hospitals, allows decision consultations, and offers capabilities of today's computer systems
and data networks to medical users. Moreover, the system is supposed to serve as a learning
tool for medical students as well as physicians in hospitals participating in this project.
The gradual development of the joint system for processing and archiving image information
is a positive step towards increasing the healthcare standard in the city of Brno as well as in
the whole region.
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facilities. Therefore, the legal barrier preventing access to sensitive and confidential patient
data is removed.
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Teaching room equipped with appropriate software can also serve as trainer for young
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radiologists. This way they can learn new technologies, compare hardware and software of
different diagnostic workstations.
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The implementation of the MeDiMed project facilitates fast communication among individual
hospitals, allows decision consultations, and offers capabilities of today's computer systems
and data networks to medical users. Moreover, the system is supposed to serve as a learning
tool for medical students as well as physicians in hospitals participating in this project.
The gradual development of the joint system for processing and archiving image information
is a positive step towards increasing the healthcare standard in the city of Brno as well as in
the whole region.
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Information on a patient's treatment in his/her own healthcare center as well as in other centers
would be available, review and consultations regarding the patient's data by more specialists
will be enabled, image information evaluation can be carried out in another place in case a
required specialist is not available in the center in question, general practitioners in the country
will be able to consult specialists in hospitals, etc. Examination results will be available for the
doctors in much shorter time than before.
The development of the system for processing, archiving and accessing the patients' image
information, designed in this way, contributes to a significant improvement of the patients’
image information and to significant improvement of the patients' care. It enables consultation
with specialists not only within a region but also outside the country. Created data files enable
practitioners to carry out evaluation of the treatment as well as administered medication in a
large sample of patients.
The new goal for the MeDiMed project is to offer PACS system to small institutions. Small
healthcare institutions and private doctor’s offices usually have limited data network availa‐
bility. They are typically located near patients and data communication is not they priority.
ICT staff in such institutions is also very limited if it exists at all. For this reason the solution
used by large hospitals is not suitable for small institutions. Even though the basic principles
used in large hospitals can be preserved also in this case.
Current ICT, as well as existing and developing standards, enable physicians to deliver some
services through the computer network. It means that medical specialists from distant
specialized departments can consult urgent cases or make decisions. It is a concept of expert
centers based on the practices of telemedicine. Image studies of every patient can be referred
to a distant expert center for a primary diagnostic or second opinion. This way a much higher
quality diagnosis can be assured.
Another important application of the shared regional PACS servers is education. Interesting
cases are anonymized and used for both education and research. The shared regional collab‐
orative environment is more than just a set of computer network applications. Gradually, it
changes the thinking of medical specialists and enables them to cooperate and share data about
patients in electronic form. It builds a network of medical specialists. The implementation of
the system has increased the speed of communication among individual hospitals, allowed
decision consultations, and brought various other advantages due to dedicated network
connections.
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1. Introduction
During prosthetic treatment, dentists need to consider various factors, such as esthetics,
speech, mastication, and swallowing, etc. Among them, the effect of prosthetic treatment on
speech is an important concern for patients; thus, dentists must take care to avoid causing
speech impairments during prosthodontic treatment, such as removable-type prostheses;
partial or complete dentures and fixed-type prostheses; bridges and crowns. Since teeth and
alveolar bone, maxillary bone are the main speech articulators, speech can be impaired by
dental disorders such as missing teeth or the presence of insufficient prostheses.
Speech, masticatory, and swallowing disorders may occur in patients after the surgical
resection of tumors with the head-and-neck region. Particularly, when a maxillary defect
remains due to the extent of tumor resection, the nasal cavity constantly communicates with
the vocal tract composed of the larynx, pharynx, and oral cavity and maxillectomy defect
changes the vocal tract shape, inducing marked speech disorder. Concretely, communication
between the nasal and oral cavities cannot be blocked, and breath passes through the nose and
it causes hypernasality, resulting in unclear phonation. Acoustically, the relationship between
the first and second formants of vowels alters [1].
However, the details have not yet been clarified. The production of vowels, an important
element of voice, depend on the vocal tract shape [2]. In the source-filter theory [3], searching
for the cause of speech disorder is considered possible based on the transfer characteristics in
the vocal tract, which is a resonant tube, determined by measuring changes in the shape.
Maxillofacial prosthetic treatment such as the use of obturators is useful for rehabilitating the
speech of maxillectomy patients as prostheses can be used to reconstruct maxillofacial defects
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including missing maxillary and alveolar bone and teeth. However, maxillofacial prosthetic
treatment often takes a long time, as the prosthesis has to be adjusted until the optimal form
has been achieved. This is particularly difficult because maxillofacial defects often have
complicated structures, and patients sometimes suffer pain in the defect area and/or trismus
Thus, a treatment protocol for maxillecyomys that is easy to apply and does not place an
unnecessary burden on patients or doctors is required. Surgeons sometimes take CT images
and MRI images of their patients to check for the presence of recurrent lesions, and we believe
that CT images and MRI images could be useful for establishing an appropriate prosthetic
treatment strategy for maxillectomy patients.
For example, if CT images and MRI images could be used to produce a speech simulation
system, it would make it easier to design prostheses with optimal forms and reduce the time
spent adjusting them.
The goal of our study is to make a vocal cord model from digital data and then use it to establish
a speech simulation system for maxillofacial prosthetics and for the preliminary survey,in this
study, we utilized an MRI images acquired while the subject phonated the sound /a/. The image
(a) 
(b) 
Figure 1. Dento-maxillary prosthesis for maxillectomy. Dento-maxillary prosthesis involves obuturator separate be‐
tween nasal part and oral part. It prevent the air leakage and works well to improve the functional impairments.
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was produced by the Advanced Telecommunications Research Institute International (ATR)
Innovative Technology for Human Communication and published by the National Institute
of Information and Communications Technology (NICT). Using this image, we prepared a
phonating vocal tract model and confirmed the acoustic features with the acoustic analysis.
2. Materials and methods
2.1. Preparation of the vocal tract model
The “MRI database of Japanese vowel production” was used according to a licensing agree‐
ment with ATR-Promotions. The database contains MR images (in the DICOM format) that
were acquired while a subject utter 5 vowels. We subjected the MRI image acquired while the
subject uttered the sound /a/ to binarization in order to add tissue to our model using the
software Mimics 11.11 (Materialise), according to the method reported by Inohara et al. [4,5]
Dentition image data from the “MRI database of Japanese vowel production” were subse‐
quently added to the image, and the vocal tract was extracted. The data were converted to the
STL format and used to produce a solid mold with a Z406 3D printer system (Z Corp.).
First, the region to be molded was selected and simulated. Since teeth are not visualized by
MRI, a toothless model was initially prepared despite the binarization method being em‐
ployed, as shown in the right figure of Fig.2, and the dentition was subsequently added. Of
the images published by ATR-Promotions, an image acquired while the subject held blueberry
jam in their mouth was adopted since blueberry jam exhibitsed a contrast medium-like effect,
and the teeth was visualized as transparent regions. Slices corresponding to the teeth were
individually extracted, and image data (Fig.3) for the dentition alone were prepared.
binarization
Figure 2. Binarization was applied to the image acquired while phonating/a/ using Mimics 111.11 following the
method reported by Inohara et al.
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Figure 3. Tooth-extracted mold was prepared Of the images published by ATR-Promotions, the image acquired while
holding blueberry jam in the mouth was adopted. Slices corresponding to the teeth were individually extracted, and
obtained image data.
The prepared dentition image data were arranged at anatomically appropriate sites on the
original image. Fig.4 shows the maxillary region after the dentition data had been added. The
mandibular region also had dentition data added to it.
Figure 4. Maxillary region combined with dentition data The prepared dentition image data were arranged at ana‐
tomically appropriate sites on the original data to combine the images. Arrows: combined dentition data
These images were converted to the STL format and used to produce solid molds with the
Z406 3D printer system at the Tsukuba Center of the National Institute of Industrial Science
and Technology.
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Figure 5. Three-dimensional model was fabricated using ZPrinter. The model was separated 4 parts: head, nasal cabi‐
ty, maxilla, mandible and pharyngteal.
2.2. Acoustic analysis
The completed vocal tract plaster models were combined, and an artificial larynx (Yourtone,
Densei Inc.) was attached to the region corresponding to the vocal folds. In this preliminary
study, a maxillary region with no defects was built. The initial maxillary region model had no
defects, which was used to represent the preoperative conditions. Phonations were recorded
for a model in a soundproof chamber. A microphone (Shure SM58) was placed 10 cm from the
lips, and the sounds were recorded using a CSL4400 Computerized Speech Lab (Kay Pentax)
and analyzed using the Wave Surfer software (KTH version 1.8.5) and the fast Fourier
transform.
Figure 6. Acoustic analysis An artificial larynx (YOURTONE, Densei Inc.) was attached to the region corresponding to
the vocal cords. A microphone was placed at a site 10cm from lips.
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Figure 3. Tooth-extracted mold was prepared Of the images published by ATR-Promotions, the image acquired while
holding blueberry jam in the mouth was adopted. Slices corresponding to the teeth were individually extracted, and
obtained image data.
The prepared dentition image data were arranged at anatomically appropriate sites on the
original image. Fig.4 shows the maxillary region after the dentition data had been added. The
mandibular region also had dentition data added to it.
Figure 4. Maxillary region combined with dentition data The prepared dentition image data were arranged at ana‐
tomically appropriate sites on the original data to combine the images. Arrows: combined dentition data
These images were converted to the STL format and used to produce solid molds with the
Z406 3D printer system at the Tsukuba Center of the National Institute of Industrial Science
and Technology.
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Figure 5. Three-dimensional model was fabricated using ZPrinter. The model was separated 4 parts: head, nasal cabi‐
ty, maxilla, mandible and pharyngteal.
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Densei Inc.) was attached to the region corresponding to the vocal folds. In this preliminary
study, a maxillary region with no defects was built. The initial maxillary region model had no
defects, which was used to represent the preoperative conditions. Phonations were recorded
for a model in a soundproof chamber. A microphone (Shure SM58) was placed 10 cm from the
lips, and the sounds were recorded using a CSL4400 Computerized Speech Lab (Kay Pentax)
and analyzed using the Wave Surfer software (KTH version 1.8.5) and the fast Fourier
transform.
Figure 6. Acoustic analysis An artificial larynx (YOURTONE, Densei Inc.) was attached to the region corresponding to
the vocal cords. A microphone was placed at a site 10cm from lips.




When a model was present, the first (F1) and second (F2) formants were observed at 613 and
1,109 Hz, respectively, and no antiformant was present. The formants produced by the model
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Figure 7. The data from 3D model
4. Discussion
We prepared a 3-dimensional model based on MRI data obtained from the “MRI database of
Japanese vowel production” published by ATR-Promotions. We used binarization to add
tissue data to an MRI image acquired during the phonation of the sound /a/ using the software
Mimics 11.11 (Materialise), according to the method reported by Inohara et al. After adding
dentition data to the image, we used the resultant image to produce a solid mold that simulated
a vocal tract that was in constant communication with the nasal cavity. We then produced
without maxillary defects which is simulated the preoperative condition for the preliminary
survey in our research. In the model and added an artificial larynx to the region corresponding
to the vocal folds.
However, we adopted an artificial larynx as the sound source, and its acoustic characteristics
obviously influenced those of the model. Thus, it is necessary to accurately investigate the
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acoustic characteristics of the model by improving the measurement conditions, such as
utilizing white noise.
Moreover, the formants produced by the model deviated from those of the original recording;
i.e., by less than 10%, but these deviations are relatively small according to a study by Takemoto
et al [6]. Our use of a model with a rigid body and the loss of sound through the boundaries
between the constituent parts of the model were considered to have caused these differences.
The model was divided into 4 separately molded parts in order to allow us to produce defects
that simulated various surgical conditions for our further study, which simulate the presence
of maxillary defect, but it might be necessary to improve the position of the joins in the model
and how they were held together.
For our further study, we would like to fabricate the models with maxilla defect which is
simulated the maxillectomy and confirm the acoustic characteristics in order to establish the
simulation system for maxillectomy patients. By making larger defects and/or changing the
defect site, our model could be used to investigate the relationship between changes in the
vocal tract and its transfer characteristics. It might also be possible to identify defect sites that
cause antiformants to be produced.
Such investigations might allow potential speech disorders to be predicted before surgery, the
modification of resection and/or reconstruction methods to avoid such problems, and the rapid
production of optimally shaped prosthetics for filling surgical defects.
5. Conclusion
From the MRI image, it is possible to make the vocal tract model and its acoustic characteristics
are confirmed with acoustic analysis
All study-related procedures and tests were approved by the Ethics Committee of Tokyo
Medical and Dental University (Approval No. 166). 269
The MRI image were obtained from the “MRI database of Japanese vowel production”, which
was constructed during research commissioned by the National Institute of Information and
Communications Technology: ‘Research and development of human information communi‐
cation’ and performed and published by the ATR Innovative Technology for Human Com‐
munication. The obtained data were used and published based on a licensing agreement with
ATR-Promotions.
The solid model was prepared with technical cooperation from Juri Yamashita and Kazumi
Fukawa at the Tsukuba Center of the National Institute of Advanced Industrial Science and
Technology.
This study was partially supported by a Grant-in-Aid for Young Scientists (B) from the
Ministry of Education, Culture, Sports, Science and Technology, Japan.
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et al [6]. Our use of a model with a rigid body and the loss of sound through the boundaries
between the constituent parts of the model were considered to have caused these differences.
The model was divided into 4 separately molded parts in order to allow us to produce defects
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of maxillary defect, but it might be necessary to improve the position of the joins in the model
and how they were held together.
For our further study, we would like to fabricate the models with maxilla defect which is
simulated the maxillectomy and confirm the acoustic characteristics in order to establish the
simulation system for maxillectomy patients. By making larger defects and/or changing the
defect site, our model could be used to investigate the relationship between changes in the
vocal tract and its transfer characteristics. It might also be possible to identify defect sites that
cause antiformants to be produced.
Such investigations might allow potential speech disorders to be predicted before surgery, the
modification of resection and/or reconstruction methods to avoid such problems, and the rapid
production of optimally shaped prosthetics for filling surgical defects.
5. Conclusion
From the MRI image, it is possible to make the vocal tract model and its acoustic characteristics
are confirmed with acoustic analysis
All study-related procedures and tests were approved by the Ethics Committee of Tokyo
Medical and Dental University (Approval No. 166). 269
The MRI image were obtained from the “MRI database of Japanese vowel production”, which
was constructed during research commissioned by the National Institute of Information and
Communications Technology: ‘Research and development of human information communi‐
cation’ and performed and published by the ATR Innovative Technology for Human Com‐
munication. The obtained data were used and published based on a licensing agreement with
ATR-Promotions.
The solid model was prepared with technical cooperation from Juri Yamashita and Kazumi
Fukawa at the Tsukuba Center of the National Institute of Advanced Industrial Science and
Technology.
This study was partially supported by a Grant-in-Aid for Young Scientists (B) from the
Ministry of Education, Culture, Sports, Science and Technology, Japan.
Development of Articulation Simulation System Using Vocal Tract Model
http://dx.doi.org/10.5772/55906
69
This study was also supported by research grants from Support for Women Researchers from
Tokyo Medical and Dental University.
Author details
Y.I. Sumita1, K. Inohara1,2, R. Sakurai3, M. Hattori1*, S. Ino4, T. Ifukube5 and H. Taniguchi1
*Address all correspondence to: sasamfp@tmd.ac.jp
1 Department of Maxillofacial Prosthetics, Graduate School, Tokyo Medical and Dental Uni‐
versity, Japan
2 Keishu-kai Inohara Dental Clinic, Japan
3 Shinjuku-nishiguchi Dental Clinic, Japan
4 Human Technology Research Institute, National Institute of Advanced Industrial Science
and Technology, Japan
5 Institute of Gerontology,The University of Tokyo, Japan
References
[1] Chiba, T, & Kajiyama, M. The Vowel, Its Nature and Structure; Tokyo-Kaiseikan
((1942).
[2] Sumita, Y. I, Ozawa, S, Mukohyama, H, Ueno, T, & Ohyama, T. Taniguchi H:Digital
acoustic analysis of five vowels in maxillectomy patients. J Oral Rehabil((2002).
[3] Stevens, K. N. Acoustic Phonetics, MIT Press ((1998).
[4] Inohara, K, Sumita, Y. I, Ohbayashi, N, Ino, S, Kurabayashi, T, Ifukube, T, & Tanigu‐
chi, H. Standardization of thresholding for binary conversion of vocal tract modeling
in Computed Tomography. J Voice,(2010).
[5] Ken Inohara, Yuka I. Sumita and Shuichi Ino ((2012). Extraction of Airway in Com‐
puted Tomography, Computed Tomography- Clinical Applications, Luca Saba (Ed.),
978-9-53307-378-1InTech, Available from: http://www.intechopen.com/books/
computed-tomography-clinical-applications/extraction-of-airway-in-computed-to‐
mography
[6] Takemoto, H, Mokhtari, P, & Kitamura, T. Acoustic analysis of the vocal tract during
vowel production by finite-difference time-domain method,” Journal of the Acousti‐
cal Society of America. 128 (6), (2010). , 3724-3738.
Selected Topics on Computed Tomography70
This study was also supported by research grants from Support for Women Researchers from
Tokyo Medical and Dental University.
Author details
Y.I. Sumita1, K. Inohara1,2, R. Sakurai3, M. Hattori1*, S. Ino4, T. Ifukube5 and H. Taniguchi1
*Address all correspondence to: sasamfp@tmd.ac.jp
1 Department of Maxillofacial Prosthetics, Graduate School, Tokyo Medical and Dental Uni‐
versity, Japan
2 Keishu-kai Inohara Dental Clinic, Japan
3 Shinjuku-nishiguchi Dental Clinic, Japan
4 Human Technology Research Institute, National Institute of Advanced Industrial Science
and Technology, Japan
5 Institute of Gerontology,The University of Tokyo, Japan
References
[1] Chiba, T, & Kajiyama, M. The Vowel, Its Nature and Structure; Tokyo-Kaiseikan
((1942).
[2] Sumita, Y. I, Ozawa, S, Mukohyama, H, Ueno, T, & Ohyama, T. Taniguchi H:Digital
acoustic analysis of five vowels in maxillectomy patients. J Oral Rehabil((2002).
[3] Stevens, K. N. Acoustic Phonetics, MIT Press ((1998).
[4] Inohara, K, Sumita, Y. I, Ohbayashi, N, Ino, S, Kurabayashi, T, Ifukube, T, & Tanigu‐
chi, H. Standardization of thresholding for binary conversion of vocal tract modeling
in Computed Tomography. J Voice,(2010).
[5] Ken Inohara, Yuka I. Sumita and Shuichi Ino ((2012). Extraction of Airway in Com‐
puted Tomography, Computed Tomography- Clinical Applications, Luca Saba (Ed.),
978-9-53307-378-1InTech, Available from: http://www.intechopen.com/books/
computed-tomography-clinical-applications/extraction-of-airway-in-computed-to‐
mography
[6] Takemoto, H, Mokhtari, P, & Kitamura, T. Acoustic analysis of the vocal tract during
vowel production by finite-difference time-domain method,” Journal of the Acousti‐
cal Society of America. 128 (6), (2010). , 3724-3738.
Selected Topics on Computed Tomography70
Selected Topics on  
Computed Tomography
Edited by Dongqing Wang
Edited by Dongqing Wang
This book is a research publication that covers developments within the Diagnostics field 
of study. The book is a collection of reviewed scholarly contributions written by different 
authors and edited by an expert with specific expertise. Each scholarly contribution 
represents a chapter which is complete in itself but related to the major topics and 
objectives. The target audience comprises scholars and specialists in the field.
Photo by nimon_t / iStock
ISBN 978-953-51-1102-3
Selected Topics on C
om
puted Tom
ography
ISBN 978-953-51-7147 8
